Stapled peptides and uses thereof
Polypeptides with specific sequences targeting GLP-1R/GIPR and GCGR provide a synergistic metabolic regulation, effectively managing diabetes and obesity by enhancing insulin secretion and improving glucose and lipid metabolism.
Patent Information
- Application Number
- JP2024527700
- Authority / Receiving Office
- JP · JP
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2021-12-09
- Filing Date
- 2022-11-08
- Publication Date
- 2024-11-21
- Estimated Expiration
- 2042-11-08
AI Technical Summary
Current treatments for diabetes, particularly type 2 diabetes, lack effective agents that can synergistically regulate glucose and lipid metabolism while minimizing the risk of hypoglycemia and providing weight management, as existing therapies often fail to address the progressive nature of the disease and its associated complications.
Development of polypeptides with specific sequences, including variants of GLP-1R/GIPR and GCGR agonists, designed to enhance insulin secretion, improve glucose and lipid metabolism, and promote weight loss, formulated as pharmaceutically acceptable salts for therapeutic use.
The polypeptides demonstrate strong agonist activity against GLP-1R/GIPR, exhibit excellent pharmacokinetic properties, and show significant hypoglycemic and weight loss effects in diabetic animal models, offering a promising therapeutic approach for diabetes and obesity.
Smart Images

Figure 2024543441000001 
Figure 2024543441000002 
Figure 2024543441000003
Abstract
Description
[Technical field]
[0001] CITED RELATED APPLICATIONS This application claims priority to and authority from Chinese Invention Patent Application No. 202111398470.4 filed with the State Intellectual Property Office of China on November 19, 2021, and Chinese Invention Patent Application No. 202111500873.5 filed with the State Intellectual Property Office of China on December 9, 2021, the entire disclosures of which are incorporated herein by reference in their entireties.
[0002] The present invention relates to a series of stapled peptides and uses thereof, specifically, to polypeptides having the sequences shown in formulas (I-1) to (I-5) and (II-6) and pharma- ceutically acceptable salts thereof. [Background technology]
[0003] Diabetes mellitus is a group of metabolic diseases characterized by hyperglycemia caused by defective insulin secretion or impaired biological effects, or both. Prolonged hyperglycemia can cause chronic damage and dysfunction in various tissues, especially the eyes, kidneys, heart, blood vessels, and nerves. According to the latest data from the International Diabetes Federation in 2019, the number of diabetes patients worldwide is approximately 460 million, and in 2020, the number of diabetes patients in China approached 130 million, making it the country with the largest number of diabetes patients in the world. According to a nationwide cross-sectional study of China published in the British Medical Journal in 2020, the prevalence of type 2 diabetes (T2D) nationwide was 11.2%, while the proportion of patients who reached the glycohemoglobin target was only 49.4%. T2D is a progressive disease, and in the later stages of the disease, there is a very high risk of developing complications such as diabetic nephropathy, diabetic retinopathy, and diabetic foot. Therefore, T2D is a major health challenge facing humanity.
[0004] Insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) are both incretins, which promote the release of insulin and are glucose-dependent, so there is a low risk of causing hypoglycemia. GLP-1 has the effects of inhibiting appetite in the brain, delaying gastric emptying, reducing hepatic gluconeogenesis, and increasing glucose consumption in muscle tissue; GIP has the effects of increasing glucose consumption in adipose tissue, promoting lipid metabolism, and preventing ectopic accumulation of fat; glucagon (GCG) is secreted from pancreatic islet alpha cells, and GCG has the effects of inhibiting hepatic fat synthesis and cholesterol levels, increasing the fat burning rate of brown adipose tissue, and protecting myocardial cells and cardiac function. Therefore, the triple agonism of GIPR, GLP-1R, and GCGR may have a synergistic effect on the regulatory function of glucose / lipid metabolism, and bring about more positive effects in lowering blood glucose levels, weight loss, reducing fatty liver, and protecting cardiovascular disease. Summary of the Invention
[0005] The present invention provides a polypeptide having the sequence shown in the formula below, or a pharma- ceutically acceptable salt thereof. Tyr-Aib-Gln-Gly-Thr-Phe-Thr-Ser-Asp-Tyr-Ser-Ile-X1-Leu-Asp-Lys- 1 Lys-Ala-Gln- 1 Lys-Ala-Phe-Ile-Glu-Tyr-Leu-Leu-Glu-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-X2(I-1), Tyr-Aib-Gln-Gly-Thr-Phe-Thr-Ser-Asp-Tyr-Ser-Ile-X1-Leu-Asp- 1 Lys-Lys-Ala- 1 Lys-Aib-Ala-Phe-Ile-Glu-Tyr-Leu-Leu-Glu-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-X2(I-2), Tyr-Aib-Gln-Gly-Thr-Phe-Thr-Ser-Asp-Tyr-Ser-Ile-X1-Leu-Asp-Lys-Lys-Ala-Gln- 1 Lys-Ala-Phe- 1 Lys-Glu-Tyr-Leu-Leu-Glu-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-X2(I-3)、 Tyr-Aib-Gln-Gly-Thr-Phe-Thr-Ser-Asp-Tyr-Ser-Ile-X1-Leu-Asp-Lys-Lys-Ala-Gln-Aib- 1 Lys-Phe-Ile- 1 Lys-Tyr-Leu-Leu-Glu-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-X2(I-4)、 Tyr-Aib-Gln-Gly-Thr-Phe-Thr-Ser-Asp-Tyr-Ser-Ile-X1-Leu-Asp-Lys-Lys-Ala-Gln-Aib-Ala-Phe-Ile-Glu- 1 Lys-Leu-Leu- 1 Lys-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-X2(I-5)、 Tyr-Aib-Gln-Gly-Thr-Phe-Thr-Ser-Asp-Tyr-Ser-Ile-X1-Leu-Asp-Lys-Lys-Ala-Gln-Aib-Ala-Phe-Ile- 1 Lys-Tyr-Leu- 1 Lys-Glu-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-X2(II-6)、 However, the structure of Aib is
Chem.
Chem.
[0006] In some embodiments of the invention, m is selected from 2, with the other variables being as defined herein.
[0007] In some embodiments of the invention, n is selected from 9, and other variables are as defined herein.
[0008] In some embodiments of the invention, p is selected from 1, with the other variables being as defined herein.
[0009] In some embodiments of the present invention, X2 is [ka] and the other variables are as defined herein.
[0010] In some embodiments of the present invention, X0 is [ka] and the other variables are as defined herein.
[0011] In some embodiments of the present invention, the structural unit [ka] teeth, [ka] and the other variables are as defined herein.
[0012] The present invention further provides a polypeptide represented by the following formula or a pharma- ceutically acceptable salt thereof: [ka] [ka] [ka] [ka] [ka] [ka]
[0013] The present invention further provides a pharmaceutical composition comprising as an active ingredient a therapeutically effective amount of the above-mentioned polypeptide or a pharma- ceutically acceptable salt thereof and a pharma- ceutically acceptable carrier.
[0014] One aspect of the invention is the use of the above-described polypeptide or a pharma- ceutically acceptable salt thereof, or the above-described pharmaceutical composition, in the manufacture of a medicament for treating diabetes and / or obesity. Effect of the Invention
[0015] The polypeptide of the present invention has strong agonistic activity against GLP-1R / GIPR, has excellent pharmacokinetic properties in multiple species, exhibits excellent weight loss effects in DIO mice, and exhibits excellent blood glucose lowering effects in db / db mice.
[0016] (Definitions and Explanations) Unless otherwise stated, the following terms and phrases used herein have the following meanings. A particular term or phrase, unless otherwise defined, should be understood as being of ordinary definition, not indefinite or unclear. When a trade name is mentioned in this specification, it refers to the corresponding product or its active ingredient.
[0017] As used herein, "pharmacologically acceptable" refers to polypeptides, materials, compositions and / or dosage forms that are within the scope of sound medical judgment, suitable for contact with human and animal tissues, without significant toxicity, irritation, allergic response or other problem or complication, and consistent with a reasonable benefit / risk ratio.
[0018] The term "pharmaceutical acceptable salt" refers to a salt of the polypeptide of the present invention, which is prepared with a relatively non-toxic acid or base, when the polypeptide has a specific substituent discovered in the present invention. When the polypeptide of the present invention contains a relatively acidic functional group, a base addition salt can be obtained by contacting these polypeptides with a sufficient amount of base in a separate solution or in a suitable inert solvent. Some specific polypeptides of the present invention contain basic and acidic functional groups, and therefore can be converted into any base addition salt or acid addition salt.
[0019] The pharma- ceutically acceptable salts of the present invention can be synthesized from parent polypeptides that contain acidic or basic groups by conventional chemical methods. Typically, such salts are prepared by reacting the polypeptides in their free acid or base form with a stoichiometric amount of the appropriate base or acid in water or an organic solvent, or a mixture of both.
[0020] "Amino acid" refers to naturally occurring and synthetic amino acids, as well as amino acid analogs and amino acid mimetics that perform a similar function to a naturally occurring amino acid. Naturally occurring amino acids are those encoded by the genetic code and those that have been subsequently modified, such as hydroxyproline, gamma-carboxyglutamate, and O-phosphoserine. Amino acid analogs are polypeptides that have the same basic chemical structure as a naturally occurring amino acid (e.g., an alpha carbon bound to a hydrogen, a carboxyl group, an amino group, and an R group), such as homoserine, norleucine, methionine sulfoxide, and methionine methylsulfonium. Such analogs may have modified R groups (e.g., norleucine) or modified peptide backbones, but retain the same basic chemical structure as a naturally occurring amino acid. Amino acid mimetics refer to compounds whose structure differs from the general chemical structure of an amino acid, but which perform a similar function to a naturally occurring amino acid.
[0021] As used herein, A or Ala represents alanine and has the structure: [ka] wherein R or Arg represents arginine and the structure is [ka] wherein N or Asn represents asparagine and the structure is [ka] where D or Asp represents aspartic acid and the structure is [ka] where C or Cys represents cysteine and the structure is [ka] where Q or Gln represents glutamine and the structure is [ka] where E or Glu represents glutamic acid and the structure is [ka] where G or Gly represents glycine and the structure is [ka] where H or His represents histidine and the structure is [ka] where I or Ile represents isoleucine and the structure is [ka] where L or Leu represents leucine and the structure is [ka] where K or Lys represents lysine and the structure is [ka] where M or Met represents methionine and the structure is [ka] where F or Phe represents phenylalanine and the structure is [ka] where P or Pro represents proline and the structure is [ka] where S or Ser represents serine and the structure is [ka] where T or Thr represents threonine and the structure is [ka] where W or Trp represents tryptophan and the structure is [ka] wherein Y or Tyr represents tyrosine and the structure is [ka] wherein V or Val represents valine and the structure is [ka] It is.
[0022] The term "treatment" includes inhibiting, alleviating, halting or reversing the progression or severity of an existing condition or disease.
[0023] Unless otherwise specified, the term "isomer" is intended to include geometric isomers, cis-trans isomers, stereoisomers, enantiomers, optical isomers, enantiomers and tautomers.
[0024] The polypeptides of the present invention may exist in particular geometric or stereoisomeric forms. The present invention contemplates all such polypeptides, including cis and trans isomers, (-)- and (+)-enantiomers, (R)- and (S)-enantiomers, diastereomers, (D)-isomers, (L)-isomers, and racemic and other mixtures thereof, such as mixtures enriched in enantiomers or diastereomers, and all such mixtures are included within the scope of the present invention. Other asymmetric carbon atoms may be present in substituents such as alkyl. All such isomers and mixtures thereof are both included within the scope of the present invention.
[0025] Unless otherwise stated, the terms "enantiomers" or "optical isomers" are stereoisomers that are mirror images of each other.
[0026] Unless otherwise stated, the terms "cis-trans isomers" or "geometric isomers" refer to the inability to freely rotate about double bonds or single bonds of ring carbon atoms.
[0027] Unless otherwise explained, the term "diastereomer" is a stereoisomer in which the molecules have two or more centers of chirality and the molecules are not mirror-images of each other.
[0028] Unless otherwise specified, "(+)" means dextrorotatory, "(-)" means levorotatory, and "(±)" means racemic. [ka]
[0029] Unless otherwise explained, the terms "enriched in one isomer," "isomer-enriched," "enriched in one enantiomer," or "enantiomer-enriched" mean that the amount of one isomer or enantiomer is less than 100% and that the amount of such isomer or enantiomer is 60% or more, or 70% or more, or 80% or more, or 90% or more, or 95% or more, or 96% or more, or 97% or more, or 98% or more, or 99% or more, or 99.5% or more, or 99.6% or more, or 99.7% or more, or 99.8% or more, or 99.9% or more.
[0030] Unless otherwise stated, the term "isomer excess" or "enantiomeric excess" refers to the difference between the relative percentages of two isomers or two enantiomers. For example, if the content of one isomer or enantiomer is 90% and the content of the other isomer or enantiomer is 10%, then the isomeric or enantiomeric excess (ee value) is 80%.
[0031] Optically active (R)- and (S)-isomers, as well as D- and L-isomers, can be prepared using asymmetric synthesis or chiral reagents or other conventional techniques. A single enantiomer of a compound of the invention can be prepared by asymmetric synthesis or derivatization with a chiral auxiliary, where the resulting diastereomeric mixture is separated and the auxiliary is resolved to provide the desired isolated enantiomer. Alternatively, if the molecule contains a basic (e.g., amino) or acidic (e.g., carboxyl) functional group, the diastereomeric salt can be formed with an appropriate optically active acid or base, and the diastereomers can be resolved by conventional methods known in the art, followed by recovery to provide the isolated enantiomers. Separation of enantiomers and diastereomers is also typically accomplished by chromatographic techniques using chiral stationary phases and any chemical derivatization techniques (e.g., carbamate formation from amines).
[0032] The compounds of the present invention may contain unnatural atomic isotopes at one or more atoms that constitute the compounds. For example, tritium ( 3 H), iodine-125( 125 I) or C-14( 14 Compounds can be labeled with radioisotopes such as radioisotopes C). Also, for example, deuterium can be replaced with hydrogen to form deuterated drugs, where the bond formed between deuterium and carbon is stronger than the bond formed between normal hydrogen and carbon, and compared to non-deuterated drugs, deuterated drugs have the advantages of reduced toxic side effects, increased drug stability, improved therapeutic efficacy, and extended biological half-life of the drug. Conversion of the isotopic composition of the compounds of the invention, whether radioactive or not, is within the scope of the invention.
[0033] If the listed linking group does not specify another linking direction, then the linking direction is arbitrary, for example: [ka] In the formula, the linking group L is -MW-, and in this case, -MW- constitutes ring A and ring B in the same direction as the reading order from left to right. [ka] You can also construct rings A and B in the reverse order of reading from left to right. [ka] Combinations of the above linking groups, substituents and / or variables are permissible only if such combinations result in stable compounds.
[0034] Unless otherwise specified, when a group has one or more bondable sites, any one or more of the sites of the group can be bonded to other groups by chemical bonds. When the bonding mode of the chemical bond is delocalized and there is an H atom at the bondable site, the number of H atoms at the site is reduced to a group with a corresponding valence according to the number of bonded chemical bonds. The chemical bond that bonds the site to another group is represented by a straight solid bond ( [ka] ), straight dashed bond ( [ka] ), or wavy line ( [ka] For example, the straight solid bond in -OCH3 means that the group is bonded to another group through its oxygen atom. [ka] A straight dashed bond within a group means that a nitrogen atom within the group is bonded at both ends to other groups. [ka]
[0035] The wavy line in the middle means that the phenyl group is bonded to another group via carbon atoms at positions 1 and 2.
[0036] Unless otherwise defined, the term "C 1-3 "Alkyl" refers to a saturated hydrocarbon group consisting of 1 to 3 carbon atoms in a straight or branched chain. 1-3 Alkyl has C 1-2 and C. 2-3 alkyl, which may be monovalent (e.g., methyl), divalent (e.g., methylene) or polyvalent (e.g., methine).1-3 Examples of alkyl include, but are not limited to, methyl (Me), ethyl (Et), propyl (including n-propyl and isopropyl).
[0037] The structure of the polypeptide of the present invention can be confirmed by conventional methods known to those skilled in the art, and when the present invention relates to the absolute configuration of a compound, the absolute configuration can be confirmed by conventional technical means of those skilled in the art. For example, single crystal X-ray diffraction (SXRD), the cultivated single crystal is collected by Bruker D8 venture diffractometer, the light source is CuKα radiation, the scanning method is φ / ω scanning, after collecting relevant data, the absolute configuration can be confirmed by direct method (Shelxs97) crystal structure analysis.
[0038] The polypeptides of the present invention can be produced by a variety of synthetic methods familiar to those of skill in the art, including the specific embodiments listed below, embodiments in combination with other chemical synthesis methods, and equivalent alternative methods familiar to those of skill in the art, and preferred embodiments include, but are not limited to, the examples of the present invention.
[0039] All solvents used in this invention can be obtained commercially.
[0040] The present invention uses the following abbreviations: aq stands for water; eq stands for equivalent; DCM stands for dichloromethane; PE stands for petroleum ether; DMSO stands for dimethylsulfoxide; MeOH stands for methanol; Boc stands for tert-butoxycarbonyl, an amine protecting group; Dde stands for (4,4-dimethyl-2,6-dioxocyclohex-1-ylidene)ethyl, an amino acid side chain protecting group; rt stands for room temperature; O / N stands for overnight run; THF stands for tetrahydrofuran; Boc2O stands for di-tert-butyl dicarbonate; TFA stands for trifluoroacetic acid; DIEA stands for diisopropylethylamine; DMF stands for N,N-dimethylformamide. HBTU represents O-(7-azabenzotriazol-1-yl)-N,N,N',N'-tetramethyluronium hexafluorophosphate; HOBT represents 1-hydroxybenzotriazole; HOAT represents 1-hydroxy-7-azabenzotriazole; DIC represents N,N'-diisopropylcarbodiimide; DBU represents 1,8-diazabicyclo[5.4.0]undec-7-ene; PhSiH3 represents phenylsilane; Pd(PPh3)4 represents tetrakis(triphenylphosphine)palladium; AEEA represents 2-(2-(2-aminoethoxy)ethoxy)acetic acid; and DIEA represents diisopropylethylamine.
[0041] Compounds are named according to conventional naming principles in the art or ChemDraw® software; for commercially available compounds, manufacturer's catalogue names are used. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
[0042] The present invention will be specifically described below by way of examples, but is not intended to be an adverse restriction of the present invention. The present invention has been described in detail herein, and specific embodiments thereof have been disclosed. It is obvious to those skilled in the art that various changes and modifications can be made in the specific embodiments of the present invention without departing from the spirit and scope of the present invention.
[0043] Intermediate 1 [ka]
[0044] 1. Hanging resin 1.1 20.0 g of chloro(o-chlorophenyl)diphenylmethane (2-CTC Resin (substitution degree S = 1.00 mmol / g)) and 7.72 g of Fmoc-AEEA-OH were weighed and added to a reaction column, and DCM (40 mL) was further added. Next, 14.0 mL of DIEA was added to the reaction column and nitrogen gas was bubbled for 2 hours. 20.0 mL of MeOH was added to the reaction column and nitrogen gas was continued to be bubbled for 30 minutes. The waste liquid was discharged until no liquid came out. DMF (300 mL) was added and washed 5 times for 1 minute each time, and the waste liquid was discharged until no liquid came out.
[0045] 1.2 20% piperidine / DMF (300 mL) was added to the reaction column, and nitrogen gas was bubbled through for 20 minutes. The waste liquid was drained until no more liquid came out. DMF (100 mL) was added and washed five times for 1 minute each, and the waste liquid was drained until no more liquid came out. Ninhydrin detection was performed and the resin was blue.
[0046] 2. Amino acid coupling 2.1 Coupling of Fmoc-AEEA-OH 1. Weigh out Fmoc-AEEA-OH (3.0 eq) and add it to the above resin, add DIEA (6.00 eq), add 120 mL of DMF to the reaction column, bubble with nitrogen gas, and add HBTU (2.85 eq) after the amino acid is dissolved. Adjust the nitrogen gas so that the resin swells evenly. 2. After reacting for 20 minutes at 25°C, ninhydrin detection was performed and the resin was colorless and transparent. 3. The reaction solution was removed by suction, and the column was washed five times with DMF for 1 minute each, and the waste liquid was drained until no more liquid came out.
[0047] 2.2 Coupling of Fmoc-Glu-OtBu 1. 20% piperidine / DMF (300 mL) was added to the reaction column, nitrogen gas was bubbled through for 20 minutes, and the waste liquid was drained until no more liquid came out. Ninhydrin detection was performed and the resin was blue in color. 2. Weigh out Fmoc-Glu-OtBu (3.0 eq) and add it to the resin, add DIEA (3.00 eq), add 300 mL of DMF to the reaction column, bubble with nitrogen gas, and add HBTU (2.85 eq) after the amino acid is dissolved. Adjust the nitrogen gas so that the resin swells evenly. 3. After reacting for 0.5 hours at 25°C, ninhydrin detection was performed and the resin was colorless and transparent. 4. The reaction solution was removed by suction, and the column was washed five times with DMF (300 mL) for 1 minute each, and the waste liquid was drained until no more liquid came out.
[0048] 2.3 Coupling of 20-(tert-butoxy)-20-oxoicosanoic acid 1. Add 20% piperidine / DMF (300mL) to the reaction column, bubble with nitrogen gas for 20 minutes, drain the waste liquid until no liquid comes out, add DMF (300mL) and wash 5 times for 1 minute each, drain the waste liquid until no liquid comes out. Ninhydrin detection was performed and the resin was blue. 2. 20-(tert-butoxy)-20-oxoicosanoic acid (3.0 eq) was weighed and added to the resin, DIEA (6.00 eq) was added, 300 mL of DMF was added to the reaction column, and nitrogen gas was bubbled in. After the amino acid was dissolved, HBTU (2.85 eq) was added. The nitrogen gas was adjusted so that the resin swelled evenly. 3. After reacting for 0.5 hours at 25°C, ninhydrin detection was performed and the resin was colorless and transparent. 4. The reaction solution was removed by suction, and the column was washed five times with DMF for 1 minute each, and the waste liquid was drained until no more liquid came out.
[0049] 3. Cleavage and Drying of Crude Peptide 3.1. Cutting fluid was prepared in the following volumes: 1,1,1,3,3,3-Hexafluoro-2-propanol (HFIP) / DCM=20 / 80.
[0050] 3.2. 400 mL of the prepared cutting solution was poured into the reactor containing the dried peptide resin, bubbled in the reactor for 20 minutes, filtered, and the filtrate was added to the flask. This procedure was repeated twice, and the cutting solution collected in the two times was spin-dried to obtain crude peptide intermediate 1.
[0051] The various types of polypeptides encompassed in the examples of the present invention are synthesized according to standard solid phase synthesis methods and purified by reverse phase HPLC.
[0052] Example 1 [ka]
[0053] 1. Weigh out 1.78 g of 4-(2',4'-dimethoxyphenyl-fluorenylmethoxycarbonyl-aminomethyl)-phenoxyacetamide-methyldiphenylmethylamine resin (Rink Amide MBHA Resin (substitution degree Sub = 0.28 mmol / g)) and add it to a reaction column. Then add DMF (50 mL) to the reaction column and bubble with nitrogen gas for 2 hours. Discharge the waste liquid until no more liquid comes out. Add DMF (50 mL) and wash 5 times for 1 minute each time and discharge the waste liquid until no more liquid comes out.
[0054] 2. 20% piperidine / DMF (50 mL) was added to the reaction column, and nitrogen gas was bubbled through for 20 minutes, and the waste liquid was drained until no more liquid came out. DMF (50 mL) was added and washed 5 times for 1 minute each, and the waste liquid was drained until no more liquid came out. Ninhydrin detection was performed, and the resin was blue.
[0055] 3. Amino acid coupling 3.1 Coupling of Fmoc-Ser(tBu)-OH 1. Weigh out Fmoc-Ser(tBu)-OH (3.0 eq) and add it to the resin, add DIEA (6.00 eq), add 10 mL of DMF to the reaction column, bubble with nitrogen gas, and add HBTU (2.85 eq) after the amino acid is dissolved. Adjust the nitrogen gas so that the resin swells evenly. 2. After reacting for 0.5 hours at 25°C, ninhydrin detection was performed and the resin was colorless and transparent. 3. The reaction solution was removed by suction, and the column was washed five times with DMF (50 mL each time for 1 min each time), and the waste liquid was drained until no more liquid came out.
[0056] 3.2 Coupling of Fmoc-Pro-OH 1. 20% piperidine / DMF (50 mL) was added to the reaction column, and nitrogen gas was bubbled through for 20 minutes, and the waste liquid was drained until no more liquid came out. DMF (50 mL) was added and washed 5 times for 1 minute each, and the waste liquid was drained until no more liquid came out. Ninhydrin detection was performed, and the resin was blue. 2. Weigh out Fmoc-Pro-OH (3.0 eq) and add it to the resin, add DIEA (6.00 eq), add 10 mL of DMF to the reaction column, bubble with nitrogen gas, and add HBTU (2.85 eq) after the amino acid is dissolved. Adjust the nitrogen gas so that the resin swells evenly. 3. After reacting for 0.5 hours at 25°C, ninhydrin detection was performed and the resin was colorless and transparent. 4. The reaction solution was removed by suction, and the column was washed five times with DMF (50 mL each time for 1 min each time), and the waste liquid was drained until no more liquid came out.
[0057] 3.3 Coupling of Fmoc-Pro-OH 1. 20% piperidine / DMF (50 mL) was added to the reaction column, and nitrogen gas was bubbled through for 20 minutes. The waste liquid was drained until no liquid came out. DMF (50 mL) was added and washed 5 times for 1 minute each, and the waste liquid was drained until no liquid came out. Chloranil detection was performed and the resin was green. 2. Weigh out Fmoc-Pro-OH (3.0 eq) and add it to the resin, add DIEA (6.00 eq), add 10 mL of DMF to the reaction column, bubble with nitrogen gas, and add HBTU (2.85 eq) after the amino acid is dissolved. Adjust the nitrogen gas so that the resin swells evenly. 3. After reacting for 0.5 hours at 25°C, chloranil detection was performed and the resin was colorless and transparent. 4. The reaction solution was removed by suction, and the column was washed five times with DMF for 1 minute each, and the waste liquid was drained until no more liquid came out.
[0058] 3.4 Coupling of Fmoc-Pro-OH 1. 20% piperidine / DMF (50 mL) was added to the reaction column, and nitrogen gas was bubbled through for 20 minutes. The waste liquid was drained until no liquid came out. DMF (50 mL) was added and washed 5 times for 1 minute each, and the waste liquid was drained until no liquid came out. Chloranil detection was performed and the resin was green. 2. Weigh out Fmoc-Pro-OH (3.0 eq) and add it to the resin, add DIEA (6.00 eq), add 10 mL of DMF to the reaction column, bubble with nitrogen gas, and add HBTU (2.85 eq) after the amino acid is dissolved. Adjust the nitrogen gas so that the resin swells evenly. 3. After reacting for 0.5 hours at 25°C, chloranil detection was performed and the resin was colorless and transparent. 4. The reaction solution was removed by suction, and the column was washed five times with DMF (50 mL each time for 1 min each time), and the waste liquid was drained until no more liquid came out.
[0059] 3.5 Coupling of Fmoc-Ala-OH 1. 20% piperidine / DMF (50 mL) was added to the reaction column, and nitrogen gas was bubbled through for 20 minutes. The waste liquid was drained until no liquid came out. DMF (50 mL) was added and washed 5 times for 1 minute each, and the waste liquid was drained until no liquid came out. Chloranil detection was performed and the resin was green. 2. Weigh out Fmoc-Ala-OH (3.0 eq) and add it to the resin, add DIEA (6.00 eq), add 10 mL of DMF to the reaction column, bubble with nitrogen gas, and add HBTU (2.85 eq) after the amino acid is dissolved. Adjust the nitrogen gas so that the resin swells evenly. 3. After reacting for 0.5 hours at 25°C, chloranil detection was performed and the resin was colorless and transparent. 4. The reaction solution was removed by suction, and the column was washed five times with DMF (50 mL each time for 1 minute each time), and the waste liquid was drained until no more liquid came out.
[0060] 3.6 Coupling of Fmoc-Gly-OH 1. 20% piperidine / DMF (50 mL) was added to the reaction column, and nitrogen gas was bubbled through for 20 minutes, and the waste liquid was drained until no more liquid came out. DMF (50 mL) was added and washed 5 times for 1 minute each, and the waste liquid was drained until no more liquid came out. Ninhydrin detection was performed, and the resin was blue. 2. Weigh out Fmoc-Gly-OH (3.0 eq) and add it to the resin, add DIEA (6.00 eq), add 10 mL of DMF to the reaction column, bubble with nitrogen gas, and add HBTU (2.85 eq) after the amino acid is dissolved. Adjust the nitrogen gas so that the resin swells evenly. 3. After reacting for 0.5 hours at 25°C, ninhydrin detection was performed and the resin was colorless and transparent. 4. The reaction solution was removed by suction, and the column was washed five times with DMF (50 mL each time for 1 min each time), and the waste liquid was drained until no more liquid came out.
[0061] 3.7 Coupling of Fmoc-Ser(tBu)-OH 1. 20% piperidine / DMF (50 mL) was added to the reaction column, and nitrogen gas was bubbled through for 20 minutes, and the waste liquid was drained until no more liquid came out. DMF (50 mL) was added and washed 5 times for 1 minute each, and the waste liquid was drained until no more liquid came out. Ninhydrin detection was performed, and the resin was blue. 2. Weigh out Fmoc-Ser(tBu)-OH (3.0 eq) and add it to the resin, add DIEA (6.00 eq), add 10 mL of DMF to the reaction column, bubble with nitrogen gas, and add HBTU (2.85 eq) after the amino acid is dissolved. Adjust the nitrogen gas so that the resin swells evenly. 3. After reacting for 0.5 hours at 25°C, ninhydrin detection was performed and the resin was colorless and transparent. 4. The reaction solution was removed by suction, and the column was washed five times with DMF (50 mL each time for 1 min each time), and the waste liquid was drained until no more liquid came out.
[0062] 3.8 Coupling of Fmoc-Ser(tBu)-OH 1. 20% piperidine / DMF (50 mL) was added to the reaction column, and nitrogen gas was bubbled through for 20 minutes, and the waste liquid was drained until no more liquid came out. DMF (50 mL) was added and washed 5 times for 1 minute each, and the waste liquid was drained until no more liquid came out. Ninhydrin detection was performed, and the resin was blue. 2. Weigh out Fmoc-Ser(tBu)-OH (3.0 eq) and add it to the resin, add DIEA (6.00 eq), add 10 mL of DMF to the reaction column, bubble with nitrogen gas, and add HBTU (2.85 eq) after the amino acid is dissolved. Adjust the nitrogen gas so that the resin swells evenly. 3. After reacting for 0.5 hours at 25°C, ninhydrin detection was performed and the resin was colorless and transparent. 4. The reaction solution was removed by suction, and the column was washed five times with DMF (50 mL each time for 1 min each time), and the waste liquid was drained until no more liquid came out.
[0063] 3.9 Coupling of Fmoc-Pro-OH 1. 20% piperidine / DMF (50 mL) was added to the reaction column, and nitrogen gas was bubbled through for 20 minutes, and the waste liquid was drained until no more liquid came out. DMF (50 mL) was added and washed 5 times for 1 minute each, and the waste liquid was drained until no more liquid came out. Ninhydrin detection was performed, and the resin was blue. 2. Weigh out Fmoc-Pro-OH (3.0 eq) and add it to the resin, add DIEA (6.00 eq), add 10 mL of DMF to the reaction column, bubble with nitrogen gas, and add HBTU (2.85 eq) after the amino acid is dissolved. Adjust the nitrogen gas so that the resin swells evenly. 3. After reacting for 0.5 hours at 25°C, ninhydrin detection was performed and the resin was colorless and transparent. 4. The reaction solution was removed by suction, and the column was washed five times with DMF (50 mL each time for 1 min each time), and the waste liquid was drained until no more liquid came out.
[0064] 3.10 Coupling of Fmoc-Gly-OH 1. 20% piperidine / DMF (50 mL) was added to the reaction column, and nitrogen gas was bubbled through for 20 minutes. The waste liquid was drained until no liquid came out. DMF (50 mL) was added and washed 5 times for 1 minute each, and the waste liquid was drained until no liquid came out. Chloranil detection was performed and the resin was green. 2. Weigh out Fmoc-Gly-OH (3.0 eq) and add it to the resin, add DIEA (6.00 eq), add 10 mL of DMF to the reaction column, bubble with nitrogen gas, and add HBTU (2.85 eq) after the amino acid is dissolved. Adjust the nitrogen gas so that the resin swells evenly. 3. After reacting for 0.5 hours at 25°C, chloranil detection was performed and the resin was colorless and transparent. 4. The reaction solution was removed by suction, and the column was washed five times with DMF (50 mL each time for 1 min each time), and the waste liquid was drained until no more liquid came out.
[0065] 3.11 Coupling of Fmoc-Gly-OH 1. 20% piperidine / DMF (50 mL) was added to the reaction column, and nitrogen gas was bubbled through for 20 minutes, and the waste liquid was drained until no more liquid came out. DMF (50 mL) was added and washed 5 times for 1 minute each, and the waste liquid was drained until no more liquid came out. Ninhydrin detection was performed, and the resin was blue. 2. Weigh out Fmoc-Gly-OH (3.0 eq) and add it to the resin, add DIEA (6.00 eq), add 10 mL of DMF to the reaction column, bubble with nitrogen gas, and add HBTU (2.85 eq) after the amino acid is dissolved. Adjust the nitrogen gas so that the resin swells evenly. 3. After reacting for 0.5 hours at 25°C, ninhydrin detection was performed and the resin was colorless and transparent. 4. The reaction solution was removed by suction, and the column was washed five times with DMF (50 mL each time for 1 min each time), and the waste liquid was drained until no more liquid came out.
[0066] 3.12 Coupling of Fmoc-Glu(OtBu)-OH 1. 20% piperidine / DMF (50 mL) was added to the reaction column, and nitrogen gas was bubbled through for 20 minutes, and the waste liquid was drained until no more liquid came out. DMF (50 mL) was added and washed 5 times for 1 minute each, and the waste liquid was drained until no more liquid came out. Ninhydrin detection was performed, and the resin was blue. 2. Weigh out Fmoc-Glu(OtBu)-OH (3.0 eq) and add it to the resin, add DIEA (6.00 eq), add 10 mL of DMF to the reaction column, bubble with nitrogen gas, and add HBTU (2.85 eq) after the amino acid is dissolved. Adjust the nitrogen gas so that the resin swells evenly. 3. After reacting for 0.5 hours at 25°C, ninhydrin detection was performed and the resin was colorless and transparent. 4. The reaction solution was removed by suction, and the column was washed five times with DMF (50 mL each time for 1 min each time), and the waste liquid was drained until no more liquid came out.
[0067] 3.13 Coupling of Fmoc-Leu-OH 1. 20% piperidine / DMF (50 mL) was added to the reaction column, and nitrogen gas was bubbled through for 20 minutes, and the waste liquid was drained until no more liquid came out. DMF (50 mL) was added and washed 5 times for 1 minute each, and the waste liquid was drained until no more liquid came out. Ninhydrin detection was performed, and the resin was blue. 2. Weigh out Fmoc-Leu-OH (3.0 eq) and add it to the resin, add DIEA (6.00 eq), add 10 mL of DMF to the reaction column, bubble with nitrogen gas, and add HBTU (2.85 eq) after the amino acid is dissolved. Adjust the nitrogen gas so that the resin swells evenly. 3. After reacting for 0.5 hours at 25°C, ninhydrin detection was performed and the resin was colorless and transparent. 4. The reaction solution was removed by suction, and the column was washed five times with DMF (50 mL each time for 1 min each time), and the waste liquid was drained until no more liquid came out.
[0068] 3.14 Coupling of Fmoc-Leu-OH 1. 20% piperidine / DMF (50 mL) was added to the reaction column, and nitrogen gas was bubbled through for 20 minutes, and the waste liquid was drained until no more liquid came out. DMF (50 mL) was added and washed 5 times for 1 minute each, and the waste liquid was drained until no more liquid came out. Ninhydrin detection was performed, and the resin was blue. 2. Weigh out Fmoc-Leu-OH (3.0 eq) and add it to the resin, add DIEA (6.00 eq), add 10 mL of DMF to the reaction column, bubble with nitrogen gas, and add HBTU (2.85 eq) after the amino acid is dissolved. Adjust the nitrogen gas so that the resin swells evenly. 3. After reacting for 0.5 hours at 25°C, ninhydrin detection was performed and the resin was colorless and transparent. 4. The reaction solution was removed by suction, and the column was washed five times with DMF (50 mL each time for 1 min each time), and the waste liquid was drained until no more liquid came out.
[0069] 3.15 Coupling of Fmoc-Tyr(tBu)-OH 1. 20% piperidine / DMF (50 mL) was added to the reaction column, and nitrogen gas was bubbled through for 20 minutes, and the waste liquid was drained until no more liquid came out. DMF (50 mL) was added and washed 5 times for 1 minute each, and the waste liquid was drained until no more liquid came out. Ninhydrin detection was performed, and the resin was blue. 2. Weigh out Fmoc-Tyr(tBu)-OH (3.0 eq) and add it to the resin, add DIEA (6.00 eq), add 10 mL of DMF to the reaction column, bubble with nitrogen gas, and add HBTU (2.85 eq) after the amino acid is dissolved. Adjust the nitrogen gas so that the resin swells evenly. 3. After reacting for 0.5 hours at 25°C, ninhydrin detection was performed and the resin was colorless and transparent. 4. The reaction solution was removed by suction, and the column was washed five times with DMF (50 mL each time for 1 min each time), and the waste liquid was drained until no more liquid came out.
[0070] 3.16 Coupling of Fmoc-Glu(OtBu)-OH 1. 20% piperidine / DMF (50 mL) was added to the reaction column, and nitrogen gas was bubbled through for 20 minutes, and the waste liquid was drained until no more liquid came out. DMF (50 mL) was added and washed 5 times for 1 minute each, and the waste liquid was drained until no more liquid came out. Ninhydrin detection was performed, and the resin was blue. 2. Weigh out Fmoc-Glu(OtBu)-OH (3.0 eq) and add it to the resin, add DIEA (6.00 eq), add 10 mL of DMF to the reaction column, bubble with nitrogen gas, and add HBTU (2.85 eq) after the amino acid is dissolved. Adjust the nitrogen gas so that the resin swells evenly. 3. After reacting for 0.5 hours at 25°C, ninhydrin detection was performed and the resin was colorless and transparent. 4. The reaction solution was removed by suction, and the column was washed five times with DMF (50 mL each time for 1 min each time), and the waste liquid was drained until no more liquid came out.
[0071] 3.17 Coupling of Fmoc-Ile-OH 1. 20% piperidine / DMF (50 mL) was added to the reaction column, and nitrogen gas was bubbled through for 20 minutes, and the waste liquid was drained until no more liquid came out. DMF (50 mL) was added and washed 5 times for 1 minute each, and the waste liquid was drained until no more liquid came out. Ninhydrin detection was performed, and the resin was blue. 2. Weigh out Fmoc-Ile-OH (3.0 eq) and add it to the resin, add DIEA (6.00 eq), add 10 mL of DMF to the reaction column, bubble with nitrogen gas, and add HBTU (2.85 eq) after the amino acid is dissolved. Adjust the nitrogen gas so that the resin swells evenly. 3. After reacting for 0.5 hours at 25°C, ninhydrin detection was performed and the resin was colorless and transparent. 4. The reaction solution was removed by suction, and the column was washed five times with DMF (50 mL each time for 1 min each time), and the waste liquid was drained until no more liquid came out.
[0072] 3.18 Coupling of Fmoc-Phe-OH 1. 20% piperidine / DMF (50 mL) was added to the reaction column, and nitrogen gas was bubbled through for 20 minutes, and the waste liquid was drained until no more liquid came out. DMF (50 mL) was added and washed 5 times for 1 minute each, and the waste liquid was drained until no more liquid came out. Ninhydrin detection was performed, and the resin was blue. 2. Weigh out Fmoc-Phe-OH (3.0 eq) and add it to the resin, add DIEA (6.00 eq), add 10 mL of DMF to the reaction column, bubble with nitrogen gas, and add HBTU (2.85 eq) after the amino acid is dissolved. Adjust the nitrogen gas so that the resin swells evenly. 3. After reacting for 0.5 hours at 25°C, ninhydrin detection was performed and the resin was colorless and transparent. 4. The reaction solution was removed by suction, and the column was washed five times with DMF (50 mL each time for 1 min each time), and the waste liquid was drained until no more liquid came out.
[0073] 3.19 Coupling of Fmoc-Ala-OH 1. 20% piperidine / DMF (50 mL) was added to the reaction column, and nitrogen gas was bubbled through for 20 minutes, and the waste liquid was drained until no more liquid came out. DMF (50 mL) was added and washed 5 times for 1 minute each, and the waste liquid was drained until no more liquid came out. Ninhydrin detection was performed, and the resin was blue. 2. Weigh out Fmoc-Ala-OH (3.0 eq) and add it to the resin, add DIEA (6.00 eq), add 10 mL of DMF to the reaction column, bubble with nitrogen gas, and add HBTU (2.85 eq) after the amino acid is dissolved. Adjust the nitrogen gas so that the resin swells evenly. 3. After reacting for 0.5 hours at 25°C, ninhydrin detection was performed and the resin was colorless and transparent. 4. The reaction solution was removed by suction, and the column was washed five times with DMF (50 mL each time for 1 min each time), and the waste liquid was drained until no more liquid came out.
[0074] 3.20 Coupling of Fmoc-Lys(Dde)-OH 1. 20% piperidine / DMF (50 mL) was added to the reaction column, and nitrogen gas was bubbled through for 20 minutes, and the waste liquid was drained until no more liquid came out. DMF (50 mL) was added and washed 5 times for 1 minute each, and the waste liquid was drained until no more liquid came out. Ninhydrin detection was performed, and the resin was blue. 2. Weigh out Fmoc-Lys(Dde)-OH (3.0 eq) and add it to the resin, add DIEA (6.00 eq), add 10 mL of DMF to the reaction column, bubble with nitrogen gas, and add HBTU (2.85 eq) after the amino acid is dissolved. Adjust the nitrogen gas so that the resin swells evenly. 3. After reacting for 0.5 hours at 25°C, ninhydrin detection was performed and the resin was colorless and transparent. 4. The reaction solution was removed by suction, and the column was washed five times with DMF (50 mL each time for 1 min each time), and the waste liquid was drained until no more liquid came out.
[0075] 3.21 Coupling of Fmoc-Gln(Trt)-OH 1. 20% piperidine / DMF (50 mL) was added to the reaction column, and nitrogen gas was bubbled through for 20 minutes, and the waste liquid was drained until no more liquid came out. DMF (50 mL) was added and washed 5 times for 1 minute each, and the waste liquid was drained until no more liquid came out. Ninhydrin detection was performed, and the resin was blue. 2. Weigh out Fmoc-Gln(Trt)-OH (3.0 eq) and add it to the resin, add DIEA (6.00 eq), add 10 mL of DMF to the reaction column, bubble with nitrogen gas, and add HBTU (2.85 eq) after the amino acid is dissolved. Adjust the nitrogen gas so that the resin swells evenly. 3. After reacting for 0.5 hours at 25°C, ninhydrin detection was performed and the resin was colorless and transparent. 4. The reaction solution was removed by suction, and the column was washed five times with DMF (50 mL each time for 1 min each time), and the waste liquid was drained until no more liquid came out.
[0076] 3.22 Coupling of Fmoc-Ala-OH 1. 20% piperidine / DMF (50 mL) was added to the reaction column, and nitrogen gas was bubbled through for 20 minutes, and the waste liquid was drained until no more liquid came out. DMF (50 mL) was added and washed 5 times for 1 minute each, and the waste liquid was drained until no more liquid came out. Ninhydrin detection was performed, and the resin was blue. 2. Weigh out Fmoc-Ala-OH (3.0 eq) and add it to the resin, add DIEA (6.00 eq), add 10 mL of DMF to the reaction column, bubble with nitrogen gas, and add HBTU (2.85 eq) after the amino acid is dissolved. Adjust the nitrogen gas so that the resin swells evenly. 3. After reacting for 0.5 hours at 25°C, ninhydrin detection was performed and the resin was colorless and transparent. 4. The reaction solution was removed by suction, and the column was washed five times with DMF (50 mL each time for 1 min each time), and the waste liquid was drained until no more liquid came out.
[0077] 3.23 Coupling of Fmoc-Lys(Alloc)-OH 1. 20% piperidine / DMF (50 mL) was added to the reaction column, and nitrogen gas was bubbled through for 20 minutes, and the waste liquid was drained until no more liquid came out. DMF (50 mL) was added and washed 5 times for 1 minute each, and the waste liquid was drained until no more liquid came out. Ninhydrin detection was performed, and the resin was blue. 2. Weigh out Fmoc-Lys(Alloc)-OH (6.0 eq) and add it to the resin, add DIEA (12.0 eq), add 10 mL of DMF to the reaction column, bubble with nitrogen gas, and add HATU (5.70 eq) after the amino acid is dissolved. Adjust the nitrogen gas so that the resin swells evenly. 3. After reacting for 0.5 hours at 25°C, ninhydrin detection was performed and the resin was colorless and transparent. 4. The reaction solution was removed by suction, and the column was washed five times with DMF (50 mL each time for 1 min each time), and the waste liquid was drained until no more liquid came out.
[0078] 3.24 Coupling of Fmoc-Lys(Boc)-OH 1. 20% piperidine / DMF (50 mL) was added to the reaction column, and nitrogen gas was bubbled through for 20 minutes, and the waste liquid was drained until no more liquid came out. DMF (50 mL) was added and washed 5 times for 1 minute each, and the waste liquid was drained until no more liquid came out. Ninhydrin detection was performed, and the resin was blue. 2. Weigh out Fmoc-Lys(Boc)-OH (6.0 eq) and add it to the resin, add DIEA (12.0 eq), add 10 mL of DMF to the reaction column, bubble with nitrogen gas, and add HATU (5.70 eq) after the amino acid is dissolved. Adjust the nitrogen gas so that the resin swells evenly. 3. After reacting for 0.5 hours at 25°C, ninhydrin detection was performed and the resin was colorless and transparent. 4. The reaction solution was removed by suction, and the column was washed five times with DMF (50 mL each time for 1 min each time), and the waste liquid was drained until no more liquid came out.
[0079] 3.25 Coupling of Fmoc-Asp(OtBu)-OH 1. 20% piperidine / DMF (50 mL) was added to the reaction column, and nitrogen gas was bubbled through for 20 minutes, and the waste liquid was drained until no more liquid came out. DMF (50 mL) was added and washed 5 times for 1 minute each, and the waste liquid was drained until no more liquid came out. Ninhydrin detection was performed, and the resin was blue. 2. Weigh out Fmoc-Asp(OtBu)-OH (6.0 eq) and add it to the resin, add DIEA (12.0 eq), add 10 mL of DMF to the reaction column, bubble with nitrogen gas, and add HATU (5.70 eq) after the amino acid is dissolved. Adjust the nitrogen gas so that the resin swells evenly. 3. After reacting for 2 hours at 25°C, ninhydrin detection was performed and the resin was blue. 4. The reaction solution was removed by suction, and the column was washed five times with DMF (50 mL each time for 1 min each time), and the waste liquid was drained until no more liquid came out.
[0080] 3.26 Coupling of Fmoc-Leu-OH 1. 20% piperidine / DMF (50 mL) was added to the reaction column, and nitrogen gas was bubbled through for 20 minutes, and the waste liquid was drained until no more liquid came out. DMF (50 mL) was added and washed 5 times for 1 minute each, and the waste liquid was drained until no more liquid came out. Ninhydrin detection was performed, and the resin was blue. 2. Weigh out Fmoc-Leu-OH (6.0 eq) and add it to the resin, then add HOAT (6.00 eq), add 10 mL of DMF to the reaction column, bubble with nitrogen gas, and add DIC (6.00 eq) after the amino acid and HOAT are dissolved. The nitrogen gas was adjusted so that the resin swells evenly. 3. After reacting for 1 hour at 25°C, ninhydrin detection was performed and the resin was colorless and transparent. 4. The reaction solution was removed by suction, and the column was washed five times with DMF (50 mL each time for 1 min each time), and the waste liquid was drained until no more liquid came out.
[0081] 3.27 Coupling of Fmoc-α-Me-Leu-OH 1. 20% piperidine / DMF (50 mL) was added to the reaction column, and nitrogen gas was bubbled through for 20 minutes, and the waste liquid was drained until no more liquid came out. DMF (50 mL) was added and washed 5 times for 1 minute each, and the waste liquid was drained until no more liquid came out. Ninhydrin detection was performed, and the resin was blue. 2. Weigh out Fmoc-α-Me-Leu-OH (6.0 eq) and add it to the resin, add DIEA (12.0 eq), add 10 mL of DMF to the reaction column, bubble with nitrogen gas, and add HATU (5.70 eq) after the amino acid is dissolved. Adjust the nitrogen gas so that the resin swells evenly. 3. After reacting for 0.5 hours at 25°C, ninhydrin detection was performed and the resin was colorless and transparent. 4. The reaction solution was removed by suction, and the column was washed five times with DMF (50 mL each time for 1 min each time), and the waste liquid was drained until no more liquid came out.
[0082] 3.28 Coupling of Fmoc-Ile-OH 1. 20% piperidine / DMF (50 mL) was added to the reaction column, and nitrogen gas was bubbled through for 20 minutes, and the waste liquid was drained until no more liquid came out. DMF (50 mL) was added and washed 5 times for 1 minute each, and the waste liquid was drained until no more liquid came out. Ninhydrin detection was performed, and the resin was blue. 2. Weigh out Fmoc-Ile-OH (6.0 eq) and add it to the resin, add DIEA (12.0 eq), add 10 mL of DMF to the reaction column, bubble with nitrogen gas, and add HATU (5.70 eq) after the amino acid is dissolved. Adjust the nitrogen gas so that the resin swells evenly. 3. After reacting for 0.5 hours at 25°C, ninhydrin detection was performed and the resin was colorless and transparent. 4. The reaction solution was removed by suction, and the column was washed five times with DMF (50 mL each time for 1 min each time), and the waste liquid was drained until no more liquid came out.
[0083] 3.29 Coupling of Fmoc-Ser(tBu)-OH 1. 20% piperidine / DMF (50 mL) was added to the reaction column, and nitrogen gas was bubbled through for 20 minutes, and the waste liquid was drained until no more liquid came out. DMF (50 mL) was added and washed 5 times for 1 minute each, and the waste liquid was drained until no more liquid came out. Ninhydrin detection was performed, and the resin was blue. 2. Weigh out Fmoc-Ser(tBu)-OH (6.0 eq) and add it to the resin, add DIEA (12.0 eq), add 10 mL of DMF to the reaction column, bubble with nitrogen gas, and add HATU (5.70 eq) after the amino acid is dissolved. Adjust the nitrogen gas so that the resin swells evenly. 3. After reacting for 0.5 hours at 25°C, ninhydrin detection was performed and the resin was colorless and transparent. 4. The reaction solution was removed by suction, and the column was washed five times with DMF (50 mL each time for 1 min each time), and the waste liquid was drained until no more liquid came out.
[0084] 3.30 Coupling of Fmoc-Tyr(tBu)-OH 1. 20% piperidine / DMF (50 mL) was added to the reaction column, and nitrogen gas was bubbled through for 20 minutes, and the waste liquid was drained until no more liquid came out. DMF (50 mL) was added and washed 5 times for 1 minute each, and the waste liquid was drained until no more liquid came out. Ninhydrin detection was performed, and the resin was blue. 2. Weigh out Fmoc-Tyr(tBu)-OH (6.0 eq) and add it to the resin, add DIEA (12.0 eq), add 10 mL of DMF to the reaction column, bubble with nitrogen gas, and after the amino acid is dissolved, add HATU (5.70 eq). Adjust the nitrogen gas so that the resin swells evenly. 3. After reacting for 0.5 hours at 25°C, ninhydrin detection was performed and the resin was colorless and transparent. 4. The reaction solution was removed by suction, and the column was washed five times with DMF (50 mL each time for 1 min each time), and the waste liquid was drained until no more liquid came out.
[0085] 3.31 Coupling of Fmoc-Asp(OtBu)-OH 1. 20% piperidine / DMF (50 mL) was added to the reaction column, and nitrogen gas was bubbled through for 20 minutes, and the waste liquid was drained until no more liquid came out. DMF (50 mL) was added and washed 5 times for 1 minute each, and the waste liquid was drained until no more liquid came out. Ninhydrin detection was performed, and the resin was blue. 2. Weigh out Fmoc-Asp(OtBu)-OH (3.0 eq) and add it to the resin, add DIEA (6.00 eq), add 10 mL of DMF to the reaction column, bubble with nitrogen gas, and add HATU (2.85 eq) after the amino acid is dissolved. Adjust the nitrogen gas so that the resin swells evenly. 3. After reacting for 0.5 hours at 25°C, ninhydrin detection was performed and the resin was colorless and transparent. 4. The reaction solution was removed by suction, and the column was washed five times with DMF (50 mL each time for 1 min each time), and the waste liquid was drained until no more liquid came out.
[0086] 3.32 Coupling of Fmoc-Ser(tBu)-OH 1. 20% piperidine / DMF (50 mL) was added to the reaction column, and nitrogen gas was bubbled through for 20 minutes, and the waste liquid was drained until no more liquid came out. DMF (50 mL) was added and washed 5 times for 1 minute each, and the waste liquid was drained until no more liquid came out. Ninhydrin detection was performed, and the resin was blue. 2. Weigh out Fmoc-Ser(tBu)-OH (6.0 eq) and add it to the resin, add HOBT (6.00 eq), add 10 mL of DMF to the reaction column, bubble with nitrogen gas, and add DIC (6.00 eq) after the amino acid and HOBT are dissolved. Adjust the nitrogen gas so that the resin swells evenly. 3. After reacting for 0.5 hours at 25°C, ninhydrin detection was performed and the resin was colorless and transparent. 4. The reaction solution was removed by suction, and the column was washed five times with DMF (50 mL each time for 1 min each time), and the waste liquid was drained until no more liquid came out.
[0087] 3.33 Coupling of Fmoc-Thr(tBu)-OH 1. 20% piperidine / DMF (50 mL) was added to the reaction column, and nitrogen gas was bubbled through for 20 minutes, and the waste liquid was drained until no more liquid came out. DMF (50 mL) was added and washed 5 times for 1 minute each, and the waste liquid was drained until no more liquid came out. Ninhydrin detection was performed, and the resin was blue. 2. Weigh out Fmoc-Thr(tBu)-OH (3.0 eq) and add it to the resin, add DIEA (6.00 eq), add 10 mL of DMF to the reaction column, bubble with nitrogen gas, and add HATU (2.85 eq) after the amino acid is dissolved. Adjust the nitrogen gas so that the resin swells evenly. 3. After reacting overnight at 25°C, ninhydrin detection was performed and the resin was colorless and transparent. 4. The reaction solution was removed by suction, and the column was washed five times with DMF (50 mL each time for 1 min each time), and the waste liquid was drained until no more liquid came out.
[0088] 3.34 Coupling of Fmoc-Phe-OH 1. 20% piperidine / DMF (50 mL) was added to the reaction column, and nitrogen gas was bubbled through for 20 minutes, and the waste liquid was drained until no more liquid came out. DMF (50 mL) was added and washed 5 times for 1 minute each, and the waste liquid was drained until no more liquid came out. Ninhydrin detection was performed, and the resin was blue. 2. Weigh out Fmoc-Phe-OH (6.0 eq) and add it to the resin, then add HOBT (6.00 eq), add 10 mL of DMF to the reaction column, bubble with nitrogen gas, and add DIC (6.00 eq) after the amino acid and HOBT are dissolved. The nitrogen gas was adjusted so that the resin swells evenly. 3. After reacting for 0.5 hours at 25°C, ninhydrin detection was performed and the resin was colorless and transparent. 4. The reaction solution was removed by suction, and the column was washed five times with DMF (50 mL each time for 1 min each time), and the waste liquid was drained until no more liquid came out.
[0089] 3.35 Coupling of Fmoc-Thr(tBu)-OH 1. 20% piperidine / DMF (50 mL) was added to the reaction column, and nitrogen gas was bubbled through for 20 minutes, and the waste liquid was drained until no more liquid came out. DMF (50 mL) was added and washed 5 times for 1 minute each, and the waste liquid was drained until no more liquid came out. Ninhydrin detection was performed, and the resin was blue. 2. Weigh out Fmoc-Thr(tBu)-OH (3.0 eq) and add it to the resin, add DIEA (6.00 eq), add 10 mL of DMF to the reaction column, bubble with nitrogen gas, and add HATU (2.85 eq) after the amino acid is dissolved. Adjust the nitrogen gas so that the resin swells evenly. 3. After reacting overnight at 25°C, ninhydrin detection was performed and the resin was colorless and transparent. 4. The reaction solution was removed by suction, and the column was washed five times with DMF (50 mL each time for 1 min each time), and the waste liquid was drained until no more liquid came out.
[0090] 3.36 Coupling of Fmoc-Gly-OH 1. 20% piperidine / DMF (50 mL) was added to the reaction column, and nitrogen gas was bubbled through for 20 minutes, and the waste liquid was drained until no more liquid came out. DMF (50 mL) was added and washed 5 times for 1 minute each, and the waste liquid was drained until no more liquid came out. Ninhydrin detection was performed, and the resin was blue. 2. Weigh out Boc-His(Trt)-OH (6.0 eq) and add it to the resin, add DIEA (12.0 eq), add 10 mL of DMF to the reaction column, bubble with nitrogen gas, and add HATU (5.70 eq) after the amino acid is dissolved. Adjust the nitrogen gas so that the resin swells evenly. 3. After reacting for 0.5 hours at 25°C, ninhydrin detection was performed and the resin was colorless and transparent. 4. The reaction solution was removed by suction, and the column was washed five times with DMF (50 mL each time for 1 min each time), and the waste liquid was drained until no more liquid came out.
[0091] 3.37 Coupling of Fmoc-Gln(Trt)-OH 1. 20% piperidine / DMF (50 mL) was added to the reaction column, and nitrogen gas was bubbled through for 20 minutes, and the waste liquid was drained until no more liquid came out. DMF (50 mL) was added and washed 5 times for 1 minute each, and the waste liquid was drained until no more liquid came out. Ninhydrin detection was performed, and the resin was blue. 2. Weigh out Fmoc-Gln(Trt)-OH (6.0 eq) and add it to the resin, add DIEA (12.0 eq), add 10 mL of DMF to the reaction column, bubble with nitrogen gas, and add HATU (5.70 eq) after the amino acid is dissolved. Adjust the nitrogen gas so that the resin swells evenly. 3. After reacting for 0.5 hours at 25°C, ninhydrin detection was performed and the resin was colorless and transparent. 4. The reaction solution was removed by suction, and the column was washed five times with DMF (50 mL each time for 1 min each time), and the waste liquid was drained until no more liquid came out.
[0092] 3.38 Coupling of Fmoc-Aib-OH 1. 20% piperidine / DMF (50 mL) was added to the reaction column, and nitrogen gas was bubbled through for 20 minutes, and the waste liquid was drained until no more liquid came out. DMF (50 mL) was added and washed 5 times for 1 minute each, and the waste liquid was drained until no more liquid came out. Ninhydrin detection was performed, and the resin was blue. 2. Weigh out Fmoc-Aib-OH (6.0 eq) and add it to the resin, add DIEA (12.0 eq), add 10 mL of DMF to the reaction column, bubble with nitrogen gas, and add HATU (5.70 eq) after the amino acid is dissolved. Adjust the nitrogen gas so that the resin swells evenly. 3. After reacting for 0.5 hours at 25°C, ninhydrin detection was performed and the resin was colorless and transparent. 4. The reaction solution was removed by suction, and the column was washed five times with DMF (50 mL each time for 1 min each time), and the waste liquid was drained until no more liquid came out.
[0093] 3.39 Coupling of Boc-Tyr(tBu)-OH 1. 20% piperidine / DMF (50 mL) was added to the reaction column, and nitrogen gas was bubbled through for 20 minutes. The waste liquid was drained until no liquid came out. DMF (50 mL) was added and washed 5 times for 1 minute each, and the waste liquid was drained until no liquid came out. Chloranil detection was performed and the resin was green. 2. Weigh out Boc-Tyr(tBu)-OH (6.0 eq) and add it to the resin, add DIEA (12.0 eq), add 10 mL of DMF to the reaction column, bubble with nitrogen gas, and add HATU (5.70 eq) after the amino acid is dissolved. Adjust the nitrogen gas so that the resin swells evenly. 3. After reacting for 0.5 hours at 25°C, chloranil detection was performed and the resin was colorless and transparent. 4. The reaction solution was removed by suction, and the column was washed five times with DMF (50 mL each time for 1 min each time), and the waste liquid was drained until no more liquid came out.
[0094] 3.40 Deprotection of Alloc 1. PhSiH3 (10.0 eq) and DCM (10 mL) were added to a reaction column and bubbled with nitrogen gas. Pd(PPh3)4 (0.1 eq) was then added and bubbled with nitrogen gas for 20 minutes. The reaction was repeated twice, and the waste liquid was discharged until no more liquid was produced. 2. Wash five times with DMF (50 mL each time for 1 min) and drain the waste liquid until no more liquid came out.
[0095] 3.41 Coupling of Fmoc-Ida-OH 1. Weigh out Fmoc-Ida-OH (CAS#:112918-82-8) (6.0eq) and add it to the above resin, add DIEA (12.0eq), add 10mL of DMF to the reaction column, bubble with nitrogen gas, and add HBTU (5.70eq) after the amino acid is dissolved. Adjust the nitrogen gas so that the resin swells evenly. 2. After reacting for 0.5 hours at 25°C, ninhydrin detection was performed and the resin was colorless and transparent. 3. The reaction solution was removed by suction, and the column was washed five times with DMF (50 mL each time for 1 min each time), and the waste liquid was drained until no more liquid came out.
[0096] 3.42 Coupling of intermediate 1 1. 10% DBU / DMF (50 mL) was added to the reaction column, and nitrogen gas was bubbled through for 20 minutes, and the waste liquid was drained until no more liquid came out. DMF (50 mL) was added and washed 5 times for 1 minute each, and the waste liquid was drained until no more liquid came out. Ninhydrin detection was performed, and the resin was blue. 2. Weigh out intermediate 1 (1.50 eq) and add it to the resin, add DIEA (3.00 eq), add 10 mL of DMF to the reaction column, bubble with nitrogen gas, and add HBTU (1.45 eq) after the amino acid is dissolved. The nitrogen gas was adjusted so that the resin swelled evenly. 3. After reacting for 0.5 hours at 25°C, ninhydrin detection was performed and the resin was colorless and transparent. 4. The reaction solution was removed by suction, and the column was washed five times with DMF (50 mL each time for 1 min each time), and the waste liquid was drained until no more liquid came out.
[0097] 3.43 Deprotection of Dde 1. Add 3% hydrazine hydrate / DMF (50mL) to the reaction column, bubble with nitrogen gas for 15 minutes, drain the waste liquid, add DMF (50mL) and wash 5 times for 1 minute each, drain the waste liquid until no liquid comes out. Ninhydrin detection was performed and the resin was blue.
[0098] 3.44 Amide ring closure 1. DIEA (3.0 eq) was added to the DMF solution of the resin, and then HATU (1.5 eq) dissolved in DMF was slowly added dropwise to the reaction column and bubbled with nitrogen gas. The nitrogen gas was adjusted so that the resin swelled evenly. 2. After reacting for 0.5 hours at 25°C, ninhydrin detection was performed and the resin was colorless and transparent. 3. The reaction solution was removed by suction, and the column was washed five times with DMF (50 mL each time for 1 min each time), and the waste liquid was drained until no more liquid came out. 4. The resin was deflated with MeOH (50 mL) for 3 min each, drained until no more liquid came out, and the resin was poured off, dried and stored.
[0099] 4. Cleavage and Drying of Crude Peptides 4.1 Cutting fluid was prepared in the following volumes: TFA / Tis / H2O / Mpr=90 / 2.5 / 2.5 / 5. 4.2 The dried peptide resin was added to the prepared cutting fluid, shaken on a shaker for 2.5 hours, filtered, and the filtrate was added to 10 volumes of ice-isopropyl ether, centrifuged, and washed five times with isopropyl ether. The crude peptide was obtained by vacuum drying for 2 hours and purified to obtain WX001. The molecular weight of the polypeptide was confirmed by ESI-MS, and the calculated value [M+3H] / 3 was 1673.2, and the detected value was 1673.0.
[0100] Example 2 [ka]
[0101] Polypeptide WX002 was obtained by referring to the synthesis of WX001. The molecular weight of the polypeptide was confirmed by ESI-MS, and the calculated value [M+3H] / 3 was 1658.9, and the detected value was 1658.7.
[0102] Example 3 [ka]
[0103] Polypeptide WX003 was obtained by referring to the synthesis of WX001. The molecular weight of the polypeptide was confirmed by ESI-MS, and the calculated value [M+3H] / 3 was 1678.2, and the detected value was 1678.1.
[0104] Example 4 [ka]
[0105] Polypeptide WX004 was obtained by referring to the synthesis of WX001. The molecular weight of the polypeptide was confirmed by ESI-MS, and the calculated value [M+3H] / 3 was 1677.6, and the detected value was 1677.6.
[0106] Example 5 [ka]
[0107] 1. Weigh out 2 g of 4-(2',4'-dimethoxyphenyl-fluorenylmethoxycarbonyl-aminomethyl)-phenoxyacetamide-methyldiphenylmethylamine resin (Rink Amide MBHA Resin (degree of substitution Sub = 0.28 mmol / g)) and add it to a reaction column. Then add DMF (50 mL) to the reaction column and bubble with nitrogen gas for 2 hours. Discharge the waste liquid until no more liquid comes out. Add DMF (50 mL) and wash 5 times for 1 minute each time and discharge the waste liquid until no more liquid comes out.
[0108] 2. 20% piperidine / DMF (50 mL) was added to the reaction column, and nitrogen gas was bubbled through for 20 minutes, and the waste liquid was drained until no more liquid came out. DMF (50 mL) was added and washed 5 times for 1 minute each, and the waste liquid was drained until no more liquid came out. Ninhydrin detection was performed, and the resin was blue.
[0109] 3. Amino acid coupling 3.1 Coupling of Fmoc-Ser(tBu)-OH 1. Weigh out Fmoc-Ser(tBu)-OH (3.0 eq) and add it to the resin, add DIEA (6.00 eq), add 10 mL of DMF to the reaction column, bubble with nitrogen gas, and add HBTU (2.85 eq) after the amino acid is dissolved. Adjust the nitrogen gas so that the resin swells evenly. 2. After reacting for 0.5 hours at 25°C, ninhydrin detection was performed and the resin was colorless and transparent. 3. The reaction solution was removed by suction, and the column was washed five times with DMF (50 mL each time for 1 min each time), and the waste liquid was drained until no more liquid came out.
[0110] 3.2 Coupling of Fmoc-Pro-OH 1. 20% piperidine / DMF (50 mL) was added to the reaction column, and nitrogen gas was bubbled through for 20 minutes, and the waste liquid was drained until no more liquid came out. DMF (50 mL) was added and washed 5 times for 1 minute each, and the waste liquid was drained until no more liquid came out. Ninhydrin detection was performed, and the resin was blue. 2. Weigh out Fmoc-Pro-OH (3.0 eq) and add it to the resin, add DIEA (6.00 eq), add 10 mL of DMF to the reaction column, bubble with nitrogen gas, and add HBTU (2.85 eq) after the amino acid is dissolved. Adjust the nitrogen gas so that the resin swells evenly. 3. After reacting for 0.5 hours at 25°C, ninhydrin detection was performed and the resin was colorless and transparent. 4. The reaction solution was removed by suction, and the column was washed five times with DMF (50 mL each time for 1 min each time), and the waste liquid was drained until no more liquid came out.
[0111] 3.3 Coupling of Fmoc-Pro-OH 1. 20% piperidine / DMF (50 mL) was added to the reaction column, and nitrogen gas was bubbled through for 20 minutes. The waste liquid was drained until no liquid came out. DMF (50 mL) was added and washed 5 times for 1 minute each, and the waste liquid was drained until no liquid came out. Chloranil detection was performed and the resin was green. 2. Weigh out Fmoc-Pro-OH (3.0 eq) and add it to the resin, add DIEA (6.00 eq), add 10 mL of DMF to the reaction column, bubble with nitrogen gas, and add HBTU (2.85 eq) after the amino acid is dissolved. Adjust the nitrogen gas so that the resin swells evenly. 3. After reacting for 0.5 hours at 25°C, chloranil detection was performed and the resin was colorless and transparent. 4. The reaction solution was removed by suction, and the column was washed five times with DMF for 1 minute each, and the waste liquid was drained until no more liquid came out.
[0112] 3.4 Coupling of Fmoc-Pro-OH 1. 20% piperidine / DMF (50 mL) was added to the reaction column, and nitrogen gas was bubbled through for 20 minutes. The waste liquid was drained until no liquid came out. DMF (50 mL) was added and washed 5 times for 1 minute each, and the waste liquid was drained until no liquid came out. Chloranil detection was performed and the resin was green. 2. Weigh out Fmoc-Pro-OH (3.0 eq) and add it to the resin, add DIEA (6.00 eq), add 10 mL of DMF to the reaction column, bubble with nitrogen gas, and add HBTU (2.85 eq) after the amino acid is dissolved. Adjust the nitrogen gas so that the resin swells evenly. 3. After reacting for 0.5 hours at 25°C, chloranil detection was performed and the resin was colorless and transparent. 4. The reaction solution was removed by suction, and the column was washed five times with DMF (50 mL each time for 1 min each time), and the waste liquid was drained until no more liquid came out.
[0113] 3.5 Coupling of Fmoc-Ala-OH 1. 20% piperidine / DMF (50 mL) was added to the reaction column, and nitrogen gas was bubbled through for 20 minutes. The waste liquid was drained until no liquid came out. DMF (50 mL) was added and washed 5 times for 1 minute each, and the waste liquid was drained until no liquid came out. Chloranil detection was performed and the resin was green. 2. Weigh out Fmoc-Ala-OH (3.0 eq) and add it to the resin, add DIEA (6.00 eq), add 10 mL of DMF to the reaction column, bubble with nitrogen gas, and add HBTU (2.85 eq) after the amino acid is dissolved. Adjust the nitrogen gas so that the resin swells evenly. 3. After reacting for 0.5 hours at 25°C, chloranil detection was performed and the resin was colorless and transparent. 4. The reaction solution was removed by suction, and the column was washed five times with DMF (50 mL each time for 1 min each time), and the waste liquid was drained until no more liquid came out.
[0114] 3.6 Coupling of Fmoc-Gly-OH 1. 20% piperidine / DMF (50 mL) was added to the reaction column, and nitrogen gas was bubbled through for 20 minutes, and the waste liquid was drained until no more liquid came out. DMF (50 mL) was added and washed 5 times for 1 minute each, and the waste liquid was drained until no more liquid came out. Ninhydrin detection was performed, and the resin was blue. 2. Weigh out Fmoc-Gly-OH (3.0 eq) and add it to the resin, add DIEA (6.00 eq), add 10 mL of DMF to the reaction column, bubble with nitrogen gas, and add HBTU (2.85 eq) after the amino acid is dissolved. Adjust the nitrogen gas so that the resin swells evenly. 3. After reacting for 0.5 hours at 25°C, ninhydrin detection was performed and the resin was colorless and transparent. 4. The reaction solution was removed by suction, and the column was washed five times with DMF (50 mL each time for 1 min each time), and the waste liquid was drained until no more liquid came out.
[0115] 3.7 Coupling of Fmoc-Ser(tBu)-OH 1. 20% piperidine / DMF (50 mL) was added to the reaction column, and nitrogen gas was bubbled through for 20 minutes, and the waste liquid was drained until no more liquid came out. DMF (50 mL) was added and washed 5 times for 1 minute each, and the waste liquid was drained until no more liquid came out. Ninhydrin detection was performed, and the resin was blue. 2. Weigh out Fmoc-Ser(tBu)-OH (3.0 eq) and add it to the resin, add DIEA (6.00 eq), add 10 mL of DMF to the reaction column, bubble with nitrogen gas, and add HBTU (2.85 eq) after the amino acid is dissolved. Adjust the nitrogen gas so that the resin swells evenly. 3. After reacting for 0.5 hours at 25°C, ninhydrin detection was performed and the resin was colorless and transparent. 4. The reaction solution was removed by suction, and the column was washed five times with DMF (50 mL each time for 1 min each time), and the waste liquid was drained until no more liquid came out.
[0116] 3.8 Coupling of Fmoc-Ser(tBu)-OH 1. 20% piperidine / DMF (50 mL) was added to the reaction column, and nitrogen gas was bubbled through for 20 minutes, and the waste liquid was drained until no more liquid came out. DMF (50 mL) was added and washed 5 times for 1 minute each, and the waste liquid was drained until no more liquid came out. Ninhydrin detection was performed, and the resin was blue. 2. Weigh out Fmoc-Ser(tBu)-OH (3.0 eq) and add it to the resin, add DIEA (6.00 eq), add 10 mL of DMF to the reaction column, bubble with nitrogen gas, and add HBTU (2.85 eq) after the amino acid is dissolved. Adjust the nitrogen gas so that the resin swells evenly. 3. After reacting for 0.5 hours at 25°C, ninhydrin detection was performed and the resin was colorless and transparent. 4. The reaction solution was removed by suction, and the column was washed five times with DMF (50 mL each time for 1 min each time), and the waste liquid was drained until no more liquid came out.
[0117] 3.9 Coupling of Fmoc-Pro-OH 1. 20% piperidine / DMF (50 mL) was added to the reaction column, and nitrogen gas was bubbled through for 20 minutes, and the waste liquid was drained until no more liquid came out. DMF (50 mL) was added and washed 5 times for 1 minute each, and the waste liquid was drained until no more liquid came out. Ninhydrin detection was performed, and the resin was blue. 2. Weigh out Fmoc-Pro-OH (3.0 eq) and add it to the resin, add DIEA (6.00 eq), add 10 mL of DMF to the reaction column, bubble with nitrogen gas, and add HBTU (2.85 eq) after the amino acid is dissolved. Adjust the nitrogen gas so that the resin swells evenly. 3. After reacting for 0.5 hours at 25°C, ninhydrin detection was performed and the resin was colorless and transparent. 4. The reaction solution was removed by suction, and the column was washed five times with DMF (50 mL each time for 1 min each time), and the waste liquid was drained until no more liquid came out.
[0118] 3.10 Coupling of Fmoc-Gly-OH 1. 20% piperidine / DMF (50 mL) was added to the reaction column, and nitrogen gas was bubbled through for 20 minutes. The waste liquid was drained until no liquid came out. DMF (50 mL) was added and washed 5 times for 1 minute each, and the waste liquid was drained until no liquid came out. Chloranil detection was performed and the resin was green. 2. Weigh out Fmoc-Gly-OH (3.0 eq) and add it to the resin, add DIEA (6.00 eq), add 10 mL of DMF to the reaction column, bubble with nitrogen gas, and add HBTU (2.85 eq) after the amino acid is dissolved. Adjust the nitrogen gas so that the resin swells evenly. 3. After reacting for 0.5 hours at 25°C, chloranil detection was performed and the resin was colorless and transparent. 4. The reaction solution was removed by suction, and the column was washed five times with DMF (50 mL each time for 1 min each time), and the waste liquid was drained until no more liquid came out.
[0119] 3.11 Coupling of Fmoc-Gly-OH 1. 20% piperidine / DMF (50 mL) was added to the reaction column, and nitrogen gas was bubbled through for 20 minutes, and the waste liquid was drained until no more liquid came out. DMF (50 mL) was added and washed 5 times for 1 minute each, and the waste liquid was drained until no more liquid came out. Ninhydrin detection was performed, and the resin was blue. 2. Weigh out Fmoc-Gly-OH (3.0 eq) and add it to the resin, add DIEA (6.00 eq), add 10 mL of DMF to the reaction column, bubble with nitrogen gas, and add HBTU (2.85 eq) after the amino acid is dissolved. Adjust the nitrogen gas so that the resin swells evenly. 3. After reacting for 0.5 hours at 25°C, ninhydrin detection was performed and the resin was colorless and transparent. 4. The reaction solution was removed by suction, and the column was washed five times with DMF (50 mL each time for 1 min each time), and the waste liquid was drained until no more liquid came out.
[0120] 3.12 Coupling of Fmoc-Lys(Dde)-OH 1. 20% piperidine / DMF (50 mL) was added to the reaction column, and nitrogen gas was bubbled through for 20 minutes, and the waste liquid was drained until no more liquid came out. DMF (50 mL) was added and washed 5 times for 1 minute each, and the waste liquid was drained until no more liquid came out. Ninhydrin detection was performed, and the resin was blue. 2. Weigh out Fmoc-Lys(Dde)-OH (3.0 eq) and add it to the resin, add DIEA (6.00 eq), add 10 mL of DMF to the reaction column, bubble with nitrogen gas, and add HBTU (2.85 eq) after the amino acid is dissolved. Adjust the nitrogen gas so that the resin swells evenly. 3. After reacting for 0.5 hours at 25°C, ninhydrin detection was performed and the resin was colorless and transparent. 4. The reaction solution was removed by suction, and the column was washed five times with DMF (50 mL each time for 1 min each time), and the waste liquid was drained until no more liquid came out.
[0121] 3.13 Coupling of Fmoc-Leu-OH 1. 20% piperidine / DMF (50 mL) was added to the reaction column, and nitrogen gas was bubbled through for 20 minutes, and the waste liquid was drained until no more liquid came out. DMF (50 mL) was added and washed 5 times for 1 minute each, and the waste liquid was drained until no more liquid came out. Ninhydrin detection was performed, and the resin was blue. 2. Weigh out Fmoc-Leu-OH (3.0 eq) and add it to the resin, add DIEA (6.00 eq), add 10 mL of DMF to the reaction column, bubble with nitrogen gas, and add HBTU (2.85 eq) after the amino acid is dissolved. Adjust the nitrogen gas so that the resin swells evenly. 3. After reacting for 0.5 hours at 25°C, ninhydrin detection was performed and the resin was colorless and transparent. 4. The reaction solution was removed by suction, and the column was washed five times with DMF (50 mL each time for 1 min each time), and the waste liquid was drained until no more liquid came out.
[0122] 3.14 Coupling of Fmoc-Leu-OH 1. 20% piperidine / DMF (50 mL) was added to the reaction column, and nitrogen gas was bubbled through for 20 minutes, and the waste liquid was drained until no more liquid came out. DMF (50 mL) was added and washed 5 times for 1 minute each, and the waste liquid was drained until no more liquid came out. Ninhydrin detection was performed, and the resin was blue. 2. Weigh out Fmoc-Leu-OH (3.0 eq) and add it to the resin, add DIEA (6.00 eq), add 10 mL of DMF to the reaction column, bubble with nitrogen gas, and add HBTU (2.85 eq) after the amino acid is dissolved. Adjust the nitrogen gas so that the resin swells evenly. 3. After reacting for 0.5 hours at 25°C, ninhydrin detection was performed and the resin was colorless and transparent. 4. The reaction solution was removed by suction, and the column was washed five times with DMF (50 mL each time for 1 min each time), and the waste liquid was drained until no more liquid came out.
[0123] 3.15 Coupling of Fmoc-Lys(Alloc)-OH 1. 20% piperidine / DMF (50 mL) was added to the reaction column, and nitrogen gas was bubbled through for 20 minutes, and the waste liquid was drained until no more liquid came out. DMF (50 mL) was added and washed 5 times for 1 minute each, and the waste liquid was drained until no more liquid came out. Ninhydrin detection was performed, and the resin was blue. 2. Weigh out Fmoc-Lys(Alloc)-OH (6.0 eq) and add it to the resin, add DIEA (12.0 eq), add 10 mL of DMF to the reaction column, bubble with nitrogen gas, and add HATU (5.70 eq) after the amino acid is dissolved. Adjust the nitrogen gas so that the resin swells evenly. 3. After reacting for 0.5 hours at 25°C, ninhydrin detection was performed and the resin was colorless and transparent. 4. The reaction solution was removed by suction, and the column was washed five times with DMF (50 mL each time for 1 min each time), and the waste liquid was drained until no more liquid came out.
[0124] 3.16 Coupling of Fmoc-Glu(OtBu)-OH 1. 20% piperidine / DMF (50 mL) was added to the reaction column, and nitrogen gas was bubbled through for 20 minutes, and the waste liquid was drained until no more liquid came out. DMF (50 mL) was added and washed 5 times for 1 minute each, and the waste liquid was drained until no more liquid came out. Ninhydrin detection was performed, and the resin was blue. 2. Weigh out Fmoc-Glu(OtBu)-OH (3.0 eq) and add it to the resin, add DIEA (6.00 eq), add 10 mL of DMF to the reaction column, bubble with nitrogen gas, and add HBTU (2.85 eq) after the amino acid is dissolved. Adjust the nitrogen gas so that the resin swells evenly. 3. After reacting for 0.5 hours at 25°C, ninhydrin detection was performed and the resin was colorless and transparent. 4. The reaction solution was removed by suction, and the column was washed five times with DMF (50 mL each time for 1 min each time), and the waste liquid was drained until no more liquid came out.
[0125] 3.17 Coupling of Fmoc-Ile-OH 1. 20% piperidine / DMF (50 mL) was added to the reaction column, and nitrogen gas was bubbled through for 20 minutes, and the waste liquid was drained until no more liquid came out. DMF (50 mL) was added and washed 5 times for 1 minute each, and the waste liquid was drained until no more liquid came out. Ninhydrin detection was performed, and the resin was blue. 2. Weigh out Fmoc-Ile-OH (3.0 eq) and add it to the resin, add DIEA (6.00 eq), add 10 mL of DMF to the reaction column, bubble with nitrogen gas, and add HBTU (2.85 eq) after the amino acid is dissolved. Adjust the nitrogen gas so that the resin swells evenly. 3. After reacting for 0.5 hours at 25°C, ninhydrin detection was performed and the resin was colorless and transparent. 4. The reaction solution was removed by suction, and the column was washed five times with DMF (50 mL each time for 1 min each time), and the waste liquid was drained until no more liquid came out.
[0126] 3.18 Coupling of Fmoc-Phe-OH 1. 20% piperidine / DMF (50 mL) was added to the reaction column, and nitrogen gas was bubbled through for 20 minutes, and the waste liquid was drained until no more liquid came out. DMF (50 mL) was added and washed 5 times for 1 minute each, and the waste liquid was drained until no more liquid came out. Ninhydrin detection was performed, and the resin was blue. 2. Weigh out Fmoc-Phe-OH (3.0 eq) and add it to the resin, add DIEA (6.00 eq), add 10 mL of DMF to the reaction column, bubble with nitrogen gas, and add HBTU (2.85 eq) after the amino acid is dissolved. Adjust the nitrogen gas so that the resin swells evenly. 3. After reacting for 0.5 hours at 25°C, ninhydrin detection was performed and the resin was colorless and transparent. 4. The reaction solution was removed by suction, and the column was washed five times with DMF (50 mL each time for 1 min each time), and the waste liquid was drained until no more liquid came out.
[0127] 3.19 Coupling of Fmoc-Ala-OH 1. 20% piperidine / DMF (50 mL) was added to the reaction column, and nitrogen gas was bubbled through for 20 minutes, and the waste liquid was drained until no more liquid came out. DMF (50 mL) was added and washed 5 times for 1 minute each, and the waste liquid was drained until no more liquid came out. Ninhydrin detection was performed, and the resin was blue. 2. Weigh out Fmoc-Ala-OH (3.0 eq) and add it to the resin, add DIEA (6.00 eq), add 10 mL of DMF to the reaction column, bubble with nitrogen gas, and add HBTU (2.85 eq) after the amino acid is dissolved. Adjust the nitrogen gas so that the resin swells evenly. 3. After reacting for 0.5 hours at 25°C, ninhydrin detection was performed and the resin was colorless and transparent. 4. The reaction solution was removed by suction, and the column was washed five times with DMF (50 mL each time for 1 min each time), and the waste liquid was drained until no more liquid came out.
[0128] 3.20 Coupling of Fmoc-Aib-OH 1. 20% piperidine / DMF (50 mL) was added to the reaction column, and nitrogen gas was bubbled through for 20 minutes, and the waste liquid was drained until no more liquid came out. DMF (50 mL) was added and washed 5 times for 1 minute each, and the waste liquid was drained until no more liquid came out. Ninhydrin detection was performed, and the resin was blue. 2. Weigh out Fmoc-Aib-OH (6.0 eq) and add it to the resin, add DIEA (12.0 eq), add 10 mL of DMF to the reaction column, bubble with nitrogen gas, and add HATU (5.70 eq) after the amino acid is dissolved. Adjust the nitrogen gas so that the resin swells evenly. 3. After reacting for 0.5 hours at 25°C, ninhydrin detection was performed and the resin was colorless and transparent. 4. The reaction solution was removed by suction, and the column was washed five times with DMF (50 mL each time for 1 min each time), and the waste liquid was drained until no more liquid came out.
[0129] 3.21 Coupling of Fmoc-Gln(Trt)-OH 1. 20% piperidine / DMF (50 mL) was added to the reaction column, and nitrogen gas was bubbled through for 20 minutes, and the waste liquid was drained until no more liquid came out. DMF (50 mL) was added and washed 5 times for 1 minute each, and the waste liquid was drained until no more liquid came out. Ninhydrin detection was performed, and the resin was blue. 2. Weigh out Fmoc-Gln(Trt)-OH (3.0 eq) and add it to the resin, add DIEA (6.00 eq), add 10 mL of DMF to the reaction column, bubble with nitrogen gas, and add HBTU (2.85 eq) after the amino acid is dissolved. Adjust the nitrogen gas so that the resin swells evenly. 3. After reacting for 0.5 hours at 25°C, ninhydrin detection was performed and the resin was colorless and transparent. 4. The reaction solution was removed by suction, and the column was washed five times with DMF (50 mL each time for 1 min each time), and the waste liquid was drained until no more liquid came out.
[0130] 3.22 Coupling of Fmoc-Ala-OH 1. 20% piperidine / DMF (50 mL) was added to the reaction column, and nitrogen gas was bubbled through for 20 minutes, and the waste liquid was drained until no more liquid came out. DMF (50 mL) was added and washed 5 times for 1 minute each, and the waste liquid was drained until no more liquid came out. Ninhydrin detection was performed, and the resin was blue. 2. Weigh out Fmoc-Ala-OH (3.0 eq) and add it to the resin, add DIEA (6.00 eq), add 10 mL of DMF to the reaction column, bubble with nitrogen gas, and add HBTU (2.85 eq) after the amino acid is dissolved. Adjust the nitrogen gas so that the resin swells evenly. 3. After reacting for 0.5 hours at 25°C, ninhydrin detection was performed and the resin was colorless and transparent. 4. The reaction solution was removed by suction, and the column was washed five times with DMF (50 mL each time for 1 min each time), and the waste liquid was drained until no more liquid came out.
[0131] 3.23 Coupling of Fmoc-Lys(Boc)-OH 1. 20% piperidine / DMF (50 mL) was added to the reaction column, and nitrogen gas was bubbled through for 20 minutes, and the waste liquid was drained until no more liquid came out. DMF (50 mL) was added and washed 5 times for 1 minute each, and the waste liquid was drained until no more liquid came out. Ninhydrin detection was performed, and the resin was blue. 2. Weigh out Fmoc-Lys(Boc)-OH (6.0 eq) and add it to the resin, add DIEA (12.0 eq), add 10 mL of DMF to the reaction column, bubble with nitrogen gas, and add HATU (5.70 eq) after the amino acid is dissolved. Adjust the nitrogen gas so that the resin swells evenly. 3. After reacting for 0.5 hours at 25°C, ninhydrin detection was performed and the resin was colorless and transparent. 4. The reaction solution was removed by suction, and the column was washed five times with DMF (50 mL each time for 1 min each time), and the waste liquid was drained until no more liquid came out.
[0132] 3.24 Coupling of Fmoc-Lys(Boc)-OH 1. 20% piperidine / DMF (50 mL) was added to the reaction column, and nitrogen gas was bubbled through for 20 minutes, and the waste liquid was drained until no more liquid came out. DMF (50 mL) was added and washed 5 times for 1 minute each, and the waste liquid was drained until no more liquid came out. Ninhydrin detection was performed, and the resin was blue. 2. Weigh out Fmoc-Lys(Boc)-OH (6.0 eq) and add it to the resin, add DIEA (12.0 eq), add 10 mL of DMF to the reaction column, bubble with nitrogen gas, and add HATU (5.70 eq) after the amino acid is dissolved. Adjust the nitrogen gas so that the resin swells evenly. 3. After reacting for 0.5 hours at 25°C, ninhydrin detection was performed and the resin was colorless and transparent. 4. The reaction solution was removed by suction, and the column was washed five times with DMF (50 mL each time for 1 min each time), and the waste liquid was drained until no more liquid came out.
[0133] 3.25 Coupling of Fmoc-Asp(OtBu)-OH 1. 20% piperidine / DMF (50 mL) was added to the reaction column, and nitrogen gas was bubbled through for 20 minutes, and the waste liquid was drained until no more liquid came out. DMF (50 mL) was added and washed 5 times for 1 minute each, and the waste liquid was drained until no more liquid came out. Ninhydrin detection was performed, and the resin was blue. 2. Weigh out Fmoc-Asp(OtBu)-OH (6.0 eq) and add it to the resin, add DIEA (12.0 eq), add 10 mL of DMF to the reaction column, bubble with nitrogen gas, and add HATU (5.70 eq) after the amino acid is dissolved. Adjust the nitrogen gas so that the resin swells evenly. 3. After reacting for 2 hours at 25°C, ninhydrin detection was performed and the resin was blue. 4. The reaction solution was removed by suction, and the column was washed five times with DMF (50 mL each time for 1 min each time), and the waste liquid was drained until no more liquid came out.
[0134] 3.26 Coupling of Fmoc-Leu-OH 1. 20% piperidine / DMF (50 mL) was added to the reaction column, and nitrogen gas was bubbled through for 20 minutes, and the waste liquid was drained until no more liquid came out. DMF (50 mL) was added and washed 5 times for 1 minute each, and the waste liquid was drained until no more liquid came out. Ninhydrin detection was performed, and the resin was blue. 2. Weigh out Fmoc-Leu-OH (6.0 eq) and add it to the resin, then add HOAT (6.00 eq), add 10 mL of DMF to the reaction column, bubble with nitrogen gas, and add DIC (6.00 eq) after the amino acid and HOAT are dissolved. The nitrogen gas was adjusted so that the resin swells evenly. 3. After reacting for 1 hour at 25°C, ninhydrin detection was performed and the resin was colorless and transparent. 4. The reaction solution was removed by suction, and the column was washed five times with DMF (50 mL each time for 1 min each time), and the waste liquid was drained until no more liquid came out.
[0135] 3.27 Coupling of Fmoc-α-Me-Leu-OH 1. 20% piperidine / DMF (50 mL) was added to the reaction column, and nitrogen gas was bubbled through for 20 minutes, and the waste liquid was drained until no more liquid came out. DMF (50 mL) was added and washed 5 times for 1 minute each, and the waste liquid was drained until no more liquid came out. Ninhydrin detection was performed, and the resin was blue. 2. Weigh out Fmoc-α-Me-Leu-OH (6.0 eq) and add it to the resin, add DIEA (12.0 eq), add 10 mL of DMF to the reaction column, bubble with nitrogen gas, and add HATU (5.70 eq) after the amino acid is dissolved. Adjust the nitrogen gas so that the resin swells evenly. 3. After reacting for 0.5 hours at 25°C, ninhydrin detection was performed and the resin was colorless and transparent. 4. The reaction solution was removed by suction, and the column was washed five times with DMF (50 mL each time for 1 min each time), and the waste liquid was drained until no more liquid came out.
[0136] 3.28 Coupling of Fmoc-Ile-OH 1. 20% piperidine / DMF (50 mL) was added to the reaction column, and nitrogen gas was bubbled through for 20 minutes, and the waste liquid was drained until no more liquid came out. DMF (50 mL) was added and washed 5 times for 1 minute each, and the waste liquid was drained until no more liquid came out. Ninhydrin detection was performed, and the resin was blue. 2. Weigh out Fmoc-Ile-OH (6.0 eq) and add it to the resin, add DIEA (12.0 eq), add 10 mL of DMF to the reaction column, bubble with nitrogen gas, and add HATU (5.70 eq) after the amino acid is dissolved. Adjust the nitrogen gas so that the resin swells evenly. 3. After reacting for 0.5 hours at 25°C, ninhydrin detection was performed and the resin was colorless and transparent. 4. The reaction solution was removed by suction, and the column was washed five times with DMF (50 mL each time for 1 min each time), and the waste liquid was drained until no more liquid came out.
[0137] 3.29 Coupling of Fmoc-Ser(tBu)-OH 1. 20% piperidine / DMF (50 mL) was added to the reaction column, and nitrogen gas was bubbled through for 20 minutes, and the waste liquid was drained until no more liquid came out. DMF (50 mL) was added and washed 5 times for 1 minute each, and the waste liquid was drained until no more liquid came out. Ninhydrin detection was performed, and the resin was blue. 2. Weigh out Fmoc-Ser(tBu)-OH (6.0 eq) and add it to the resin, add DIEA (12.0 eq), add 10 mL of DMF to the reaction column, bubble with nitrogen gas, and add HATU (5.70 eq) after the amino acid is dissolved. Adjust the nitrogen gas so that the resin swells evenly. 3. After reacting for 0.5 hours at 25°C, ninhydrin detection was performed and the resin was colorless and transparent. 4. The reaction solution was removed by suction, and the column was washed five times with DMF (50 mL each time for 1 min each time), and the waste liquid was drained until no more liquid came out.
[0138] 3.30 Coupling of Fmoc-Tyr(tBu)-OH 1. 20% piperidine / DMF (50 mL) was added to the reaction column, and nitrogen gas was bubbled through for 20 minutes, and the waste liquid was drained until no more liquid came out. DMF (50 mL) was added and washed 5 times for 1 minute each, and the waste liquid was drained until no more liquid came out. Ninhydrin detection was performed, and the resin was blue. 2. Weigh out Fmoc-Tyr(tBu)-OH (6.0 eq) and add it to the resin, add DIEA (12.0 eq), add 10 mL of DMF to the reaction column, bubble with nitrogen gas, and after the amino acid is dissolved, add HATU (5.70 eq). Adjust the nitrogen gas so that the resin swells evenly. 3. After reacting for 0.5 hours at 25°C, ninhydrin detection was performed and the resin was colorless and transparent. 4. The reaction solution was removed by suction, and the column was washed five times with DMF (50 mL each time for 1 min each time), and the waste liquid was drained until no more liquid came out.
[0139] 3.31 Coupling of Fmoc-Asp(OtBu)-OH 1. 20% piperidine / DMF (50 mL) was added to the reaction column, and nitrogen gas was bubbled through for 20 minutes, and the waste liquid was drained until no more liquid came out. DMF (50 mL) was added and washed 5 times for 1 minute each, and the waste liquid was drained until no more liquid came out. Ninhydrin detection was performed, and the resin was blue. 2. Weigh out Fmoc-Asp(OtBu)-OH (3.0 eq) and add it to the resin, add DIEA (6.00 eq), add 10 mL of DMF to the reaction column, bubble with nitrogen gas, and add HATU (2.85 eq) after the amino acid is dissolved. Adjust the nitrogen gas so that the resin swells evenly. 3. After reacting for 0.5 hours at 25°C, ninhydrin detection was performed and the resin was colorless and transparent. 4. The reaction solution was removed by suction, and the column was washed five times with DMF (50 mL each time for 1 min each time), and the waste liquid was drained until no more liquid came out.
[0140] 3.32 Coupling of Fmoc-Ser(tBu)-OH 1. 20% piperidine / DMF (50 mL) was added to the reaction column, and nitrogen gas was bubbled through for 20 minutes, and the waste liquid was drained until no more liquid came out. DMF (50 mL) was added and washed 5 times for 1 minute each, and the waste liquid was drained until no more liquid came out. Ninhydrin detection was performed, and the resin was blue. 2. Weigh out Fmoc-Ser(tBu)-OH (6.0 eq) and add it to the resin, add HOBT (6.00 eq), add 10 mL of DMF to the reaction column, bubble with nitrogen gas, and add DIC (6.00 eq) after the amino acid and HOBT are dissolved. Adjust the nitrogen gas so that the resin swells evenly. 3. After reacting for 0.5 hours at 25°C, ninhydrin detection was performed and the resin was colorless and transparent. 4. The reaction solution was removed by suction, and the column was washed five times with DMF (50 mL each time for 1 min each time), and the waste liquid was drained until no more liquid came out.
[0141] 3.33 Coupling of Fmoc-Thr(tBu)-OH 1. 20% piperidine / DMF (50 mL) was added to the reaction column, and nitrogen gas was bubbled through for 20 minutes, and the waste liquid was drained until no more liquid came out. DMF (50 mL) was added and washed 5 times for 1 minute each, and the waste liquid was drained until no more liquid came out. Ninhydrin detection was performed, and the resin was blue. 2. Weigh out Fmoc-Thr(tBu)-OH (3.0 eq) and add it to the resin, add DIEA (6.00 eq), add 10 mL of DMF to the reaction column, bubble with nitrogen gas, and add HATU (2.85 eq) after the amino acid is dissolved. Adjust the nitrogen gas so that the resin swells evenly. 3. After reacting overnight at 25°C, ninhydrin detection was performed and the resin was colorless and transparent. 4. The reaction solution was removed by suction, and the column was washed five times with DMF (50 mL each time for 1 min each time), and the waste liquid was drained until no more liquid came out.
[0142] 3.34 Coupling of Fmoc-Phe-OH 1. 20% piperidine / DMF (50 mL) was added to the reaction column, and nitrogen gas was bubbled through for 20 minutes, and the waste liquid was drained until no more liquid came out. DMF (50 mL) was added and washed 5 times for 1 minute each, and the waste liquid was drained until no more liquid came out. Ninhydrin detection was performed, and the resin was blue. 2. Weigh out Fmoc-Phe-OH (6.0 eq) and add it to the resin, then add HOBT (6.00 eq), add 10 mL of DMF to the reaction column, bubble with nitrogen gas, and add DIC (6.00 eq) after the amino acid and HOBT are dissolved. The nitrogen gas was adjusted so that the resin swells evenly. 3. After reacting for 0.5 hours at 25°C, ninhydrin detection was performed and the resin was colorless and transparent. 4. The reaction solution was removed by suction, and the column was washed five times with DMF (50 mL each time for 1 min each time), and the waste liquid was drained until no more liquid came out.
[0143] 3.35 Coupling of Fmoc-Thr(tBu)-OH 1. 20% piperidine / DMF (50 mL) was added to the reaction column, and nitrogen gas was bubbled through for 20 minutes, and the waste liquid was drained until no more liquid came out. DMF (50 mL) was added and washed 5 times for 1 minute each, and the waste liquid was drained until no more liquid came out. Ninhydrin detection was performed, and the resin was blue. 2. Weigh out Fmoc-Thr(tBu)-OH (3.0 eq) and add it to the resin, add DIEA (6.00 eq), add 10 mL of DMF to the reaction column, bubble with nitrogen gas, and add HATU (2.85 eq) after the amino acid is dissolved. Adjust the nitrogen gas so that the resin swells evenly. 3. After reacting overnight at 25°C, ninhydrin detection was performed and the resin was colorless and transparent. 4. The reaction solution was removed by suction, and the column was washed five times with DMF (50 mL each time for 1 min each time), and the waste liquid was drained until no more liquid came out.
[0144] 3.36 Coupling of Fmoc-Gly-OH 1. 20% piperidine / DMF (50 mL) was added to the reaction column, and nitrogen gas was bubbled through for 20 minutes, and the waste liquid was drained until no more liquid came out. DMF (50 mL) was added and washed 5 times for 1 minute each, and the waste liquid was drained until no more liquid came out. Ninhydrin detection was performed, and the resin was blue. 2. Weigh out Boc-His(Trt)-OH (6.0 eq) and add it to the resin, add DIEA (12.0 eq), add 10 mL of DMF to the reaction column, bubble with nitrogen gas, and add HATU (5.70 eq) after the amino acid is dissolved. Adjust the nitrogen gas so that the resin swells evenly. 3. After reacting for 0.5 hours at 25°C, ninhydrin detection was performed and the resin was colorless and transparent. 4. The reaction solution was removed by suction, and the column was washed five times with DMF (50 mL each time for 1 min each time), and the waste liquid was drained until no more liquid came out.
[0145] 3.37 Coupling of Fmoc-Gln(Trt)-OH 1. 20% piperidine / DMF (50 mL) was added to the reaction column, and nitrogen gas was bubbled through for 20 minutes, and the waste liquid was drained until no more liquid came out. DMF (50 mL) was added and washed 5 times for 1 minute each, and the waste liquid was drained until no more liquid came out. Ninhydrin detection was performed, and the resin was blue. 2. Weigh out Fmoc-Gln(Trt)-OH (6.0 eq) and add it to the resin, add DIEA (12.0 eq), add 10 mL of DMF to the reaction column, bubble with nitrogen gas, and add HATU (5.70 eq) after the amino acid is dissolved. Adjust the nitrogen gas so that the resin swells evenly. 3. After reacting for 0.5 hours at 25°C, ninhydrin detection was performed and the resin was colorless and transparent. 4. The reaction solution was removed by suction, and the column was washed five times with DMF (50 mL each time for 1 min each time), and the waste liquid was drained until no more liquid came out.
[0146] 3.38 Coupling of Fmoc-Aib-OH 1. 20% piperidine / DMF (50 mL) was added to the reaction column, and nitrogen gas was bubbled through for 20 minutes, and the waste liquid was drained until no more liquid came out. DMF (50 mL) was added and washed 5 times for 1 minute each, and the waste liquid was drained until no more liquid came out. Ninhydrin detection was performed, and the resin was blue. 2. Weigh out Fmoc-Aib-OH (6.0 eq) and add it to the resin, add DIEA (12.0 eq), add 10 mL of DMF to the reaction column, bubble with nitrogen gas, and add HATU (5.70 eq) after the amino acid is dissolved. Adjust the nitrogen gas so that the resin swells evenly. 3. After reacting for 0.5 hours at 25°C, ninhydrin detection was performed and the resin was colorless and transparent. 4. The reaction solution was removed by suction, and the column was washed five times with DMF (50 mL each time for 1 min each time), and the waste liquid was drained until no more liquid came out.
[0147] 3.39 Coupling of Boc-Tyr(tBu)-OH 1. 20% piperidine / DMF (50 mL) was added to the reaction column, and nitrogen gas was bubbled through for 20 minutes. The waste liquid was drained until no liquid came out. DMF (50 mL) was added and washed 5 times for 1 minute each, and the waste liquid was drained until no liquid came out. Chloranil detection was performed and the resin was green. 2. Weigh out Boc-Tyr(tBu)-OH (6.0 eq) and add it to the resin, add DIEA (12.0 eq), add 10 mL of DMF to the reaction column, bubble with nitrogen gas, and add HATU (5.70 eq) after the amino acid is dissolved. Adjust the nitrogen gas so that the resin swells evenly. 3. After reacting for 0.5 hours at 25°C, chloranil detection was performed and the resin was colorless and transparent. 4. The reaction solution was removed by suction, and the column was washed five times with DMF (50 mL each time for 1 min each time), and the waste liquid was drained until no more liquid came out.
[0148] 3.40 Deprotection of Alloc 1. PhSiH3 (10.0 eq) and DCM (10 mL) were added to a reaction column and bubbled with nitrogen gas. Pd(PPh3)4 (0.1 eq) was then added and bubbled with nitrogen gas for 20 minutes. The reaction was repeated twice, and the waste liquid was discharged until no more liquid was produced. 2. Wash five times with DMF (50 mL each time for 1 min) and drain the waste liquid until no more liquid came out.
[0149] 3.41 Coupling of Fmoc-Ida-OH 1. Weigh out Fmoc-Ida-OH (6.0 eq) and add it to the above resin, add DIEA (12.0 eq), add 10 mL of DMF to the reaction column, bubble with nitrogen gas, and add HBTU (5.70 eq) after the amino acid is dissolved. Adjust the nitrogen gas so that the resin swells evenly. 2. After reacting for 0.5 hours at 25°C, ninhydrin detection was performed and the resin was colorless and transparent. 3. The reaction solution was removed by suction, and the column was washed five times with DMF (50 mL each time for 1 min each time), and the waste liquid was drained until no more liquid came out.
[0150] 3.42 Coupling of intermediate 1 1. 10% DBU / DMF (50 mL) was added to the reaction column, and nitrogen gas was bubbled through for 20 minutes, and the waste liquid was drained until no more liquid came out. DMF (50 mL) was added and washed 5 times for 1 minute each, and the waste liquid was drained until no more liquid came out. Ninhydrin detection was performed, and the resin was blue. 2. Weigh out intermediate 1 (1.50 eq) and add it to the resin, add DIEA (3.00 eq), add 10 mL of DMF to the reaction column, bubble with nitrogen gas, and add HBTU (1.45 eq) after the amino acid is dissolved. Adjust the nitrogen gas so that the resin swells evenly. 3. After reacting for 0.5 hours at 25°C, ninhydrin detection was performed and the resin was colorless and transparent. 4. The reaction solution was removed by suction, and the column was washed five times with DMF (50 mL each time for 1 min each time), and the waste liquid was drained until no more liquid came out.
[0151] 3.43 Deprotection of Dde 1. Add 3% hydrazine hydrate / DMF (50mL) to the reaction column, bubble with nitrogen gas for 15 minutes, drain the waste liquid, add DMF (50mL) and wash 5 times for 1 minute each, drain the waste liquid until no liquid comes out. Ninhydrin detection was performed and the resin was blue.
[0152] 3.44 Amide ring closure 1. DIEA (3.0 eq) was added to the DMF solution of the resin, and then HATU (1.5 eq) dissolved in DMF was slowly added dropwise to the reaction column and bubbled with nitrogen gas. The nitrogen gas was adjusted so that the resin swelled evenly. 2. After reacting for 0.5 hours at 25°C, ninhydrin detection was performed and the resin was colorless and transparent. 3. The reaction solution was removed by suction, and the column was washed five times with DMF (50 mL each time for 1 min each time), and the waste liquid was drained until no more liquid came out. 4. The resin was deflated with MeOH (50 mL) for 3 min each, drained until no more liquid came out, and the resin was poured off, dried and stored.
[0153] 4. Cleavage and Drying of Crude Peptides 4.1 Cutting fluid was prepared in the following volumes: TFA / Tis / H2O / Mpr=90 / 2.5 / 2.5 / 5. The dried peptide resin was added to the prepared cutting fluid, shaken on a shaker for 2.5 hours, filtered, and the filtrate was added to 10 volumes of ice-isopropyl ether, centrifuged, and washed five times with isopropyl ether. The crude peptide was obtained after drying in vacuum for 2 hours, and purified to obtain polypeptide WX005. The molecular weight of the polypeptide was confirmed by ESI-MS, and the calculated value [M+3H] / 3 was 1646.9, and the detected value was 1646.9.
[0154] Example 6 [ka]
[0155] Polypeptide WX006 was obtained by referring to the synthesis of WX001. The molecular weight of the polypeptide was confirmed by ESI-MS, and the calculated value [M+3H] / 3 was 1663.5, and the detected value was 1663.3.
[0156] Biological Test Data Experimental Example 1: In vitro GLP-1R / GIPR / GCGR agonist activity test A: Main materials 1) Cell line The cell line was constructed by Shanghai WuXi AppTec New Pharmaceutical Development Co., Ltd. The details are shown in Table 1. [Table 1]
[0157] 2) Reagents and consumables are as shown in Table 2: [Table 2]
[0158] 3) The equipment is as shown in Table 3: [Table 3]
[0159] B. Method I) Experimental materials The experimental buffers are as shown in Table 4: [Table 4]
[0160] The preparation of detection reagents is as shown in Table 5: [Table 5]
[0161] II) Experimental Method a) Preparation of compound plates: Test compounds were diluted 4-fold in 10-point series with a starting concentration of 30 μM and dilutions were completed in a Bravo.
[0162] b) Compound transfer: 1) 100 nL of compound was transferred to an OptiPlate-384 plate using an Echo. 2) The OptiPlate-384 plate was centrifuged at 1000 rpm for 5 seconds.
[0163] c) Preparation of cell suspension 1) One GLP-1R / GIPR / GCGR cell freezing tube was placed in 37°C warm water and allowed to thaw quickly. 2) The cell suspension was transferred to a 15 mL centrifuge tube and gently rinsed with 10 mL of HBSS. 3) The tube was centrifuged at 1000 rpm at room temperature for 1 minute. 4) The supernatant was discarded. 5) The cells at the bottom were gently dispersed, gently rinsed with 10 mL of HBSS, centrifuged to sediment the cells, and finally resuspended in the test buffer. 6) Cell density and viability were measured using Vi-cell. 7) GLP-1R / GIPR / GCGR cell concentration was 2.0 x 10 in test buffer. 5 / mL. 8) 100 nL of the diluted cell suspension was placed into an OptiPlate-384 plate. 9) Incubated at room temperature for 30 minutes.
[0164] d) Addition of detection reagent: 1) 10 μL of 800 nM gradient diluted cAMP standard was added to blank wells of an OptiPlate-384 plate. 2) 10 μL of cAMP detection reagent was added. 3) The OptiPlate-384 plate was covered with TopSeal-A film and incubated at room temperature for 60 minutes. TopSeal-A was removed and the data was read using EnVision.
[0165] C. The experimental results are shown in Table 6. [Table 6]
[0166] Conclusion: The polypeptides of the present invention have strong agonistic activity against GLP-1R / GIPR. Among them, different peptides have large differences in agonistic activity against GCG, which is an important guide for studying the balance of activity of the three targets.
[0167] Experimental Example 2: Pharmacokinetic evaluation in rats A. Purpose of the experiment The purpose is to test the pharmacokinetics of the polypeptide of the present invention in the body of SD rats.
[0168] B. Experimental Procedure The pharmacokinetic properties of the polypeptide of the present invention in rodents after subcutaneous injection were tested by standard protocol, in which the polypeptide was prepared into a clear solution and then administered to rats by a single subcutaneous injection (SC, 0.048mpk). The injection solvent was citrate buffer (20mM, pH=7). Whole blood was collected to prepare plasma, which was analyzed for drug concentration by LC-MS / MS method, and pharmacokinetic parameters were calculated by Phoenix WinNonlin software.
[0169] C. Experimental Results The experimental results are shown in Table 7. [Table 7]
[0170] Conclusion: The polypeptide of the present invention has excellent pharmacokinetic properties in rats.
[0171] Experimental Example 3: Pharmacokinetic evaluation in mice A. Purpose of the experiment The purpose was to test the pharmacokinetics of the polypeptide of the present invention in C57BL / 6 mice.
[0172] B. Experimental Procedure The pharmacokinetic properties of the polypeptide of the present invention in rodents after intravenous and subcutaneous injection were tested by standard protocols, in which the polypeptide was prepared into a clear solution and then administered to mice by a single subcutaneous injection (SC, 0.048mpk). The subcutaneous injection solvent was citrate buffer (20mM, pH=7). Whole blood was collected to prepare plasma, which was analyzed for drug concentration by LC-MS / MS method, and pharmacokinetic parameters were calculated by Phoenix WinNonlin software.
[0173] C. Experimental Results The experimental results are shown in Table 8. [Table 8]
[0174] Conclusion: The polypeptide of the present invention has excellent pharmacokinetic properties in mice.
[0175] Experimental Example 4: Pharmacokinetic evaluation in cynomolgus monkeys A. Purpose of the experiment The purpose is to test the pharmacokinetics of the polypeptide of the present invention in cynomolgus monkeys.
[0176] B. Experimental Procedure The pharmacokinetic properties of the polypeptide of the present invention in mammals after intravenous and subcutaneous injection were tested by standard protocol. In the experiment, the polypeptide was prepared into a clear solution and then administered to cynomolgus monkeys by a single subcutaneous injection (SC, 0.02mpk). The subcutaneous injection solvent was citrate buffer (20mM, pH=7). Whole blood was collected to prepare plasma, and the drug concentration was analyzed by LC-MS / MS method, and the pharmacokinetic parameters were calculated by Phoenix WinNonlin software.
[0177] C. Experimental Results The experimental results are shown in Table 9. [Table 9]
[0178] Conclusion: The polypeptides of the present invention have excellent pharmacokinetic properties in monkeys.
[0179] Experimental Example 5: Drug efficacy study in DIO mice - In vivo drug efficacy evaluation A. Purpose of the experiment The purpose is to study the weight loss effect of the polypeptide of the present invention in DIO mice.
[0180] B. Experimental Procedure After arriving at the WuXi AppTec facility, the DIO mice were housed in a strictly environmentally controlled animal room with a temperature of 20–24°C and humidity of 30–70%. The temperature and humidity in the animal room were monitored with a thermohygrometer, and the temperature and humidity were recorded twice a day (once in the morning and once in the afternoon). The light in the animal room was controlled by an electronic timing lighting system, with 12 hours of light on and 12 hours of dark every day (lights on at 7:00 a.m. and off at 7:00 p.m.). During the experiment, the animals were housed in single cages, and toys were provided in each cage. During the experiment, the animals had free access to food (rat and mouse growth / breeding chow) and drinking water.
[0181] 2. Animals in each group were subcutaneously injected with the solvent (20 mM sodium citrate buffer, pH=7.0) and the polypeptide of the present invention (10 nmol / kg), administration time: 9:30 a.m., administration frequency: once every 3 days, administration cycle: 22 days.
[0182] C. Experimental Results The experimental results are shown in Table 10. [Table 10]
[0183] Conclusion: The polypeptide of the present invention showed excellent weight loss effect in DIO mice.
[0184] Experimental Example 6: Drug efficacy study in db / db mice - In vivo drug efficacy evaluation A. Purpose of the experiment The purpose is to study the blood glucose control effect of the polypeptide of the present invention on type II diabetic db / db mice.
[0185] B. Experimental Procedure After arriving at the facility, the db / db mice were housed in a strictly environmentally controlled animal room with a temperature of 20–24°C and humidity of 30–70%. The temperature and humidity in the room were monitored with a thermohygrometer, and the temperature and humidity were recorded twice a day (once in the morning and once in the afternoon). The light in the animal room was controlled by an electronic timing lighting system, with the lights on for 12 hours and off for 12 hours every day (lights on at 7:00 a.m. and off at 7:00 p.m.). During the experiment, the animals were housed in single cages, and each cage was provided with a toy. During the experiment, the animals had free access to food (rat and mouse growth / breeding chow) and drinking water.
[0186] 2. Animals in each group were subcutaneously injected with a solvent (20 mM sodium citrate buffer, pH=7.0) and the polypeptide of the present invention (15 nmol / kg), with the administration time being 9:30 to 11:00 a.m. and the administration frequency being once a day for four consecutive weeks.
[0187] C. Experimental Results The experimental results are shown in Table 11. [Table 11]
[0188] Conclusion: The polypeptide of the present invention exhibits excellent blood glucose lowering effects in db / db mice.
Claims
1. A polypeptide having an array represented by the following formula or a pharmaceutically acceptable salt thereof. Tyr - Aib - Gln - Gly - Thr - Phe - Thr - Ser - Asp - Tyr - Ser - Ile - X 1 - Leu - Asp - Lys - 1 Lys - Ala - Gln - 1 Lys - Ala - Phe - Ile - Glu - Tyr - Leu - Leu - Glu - Gly - Gly - Pro - Ser - Ser - Gly - Ala - Pro - Pro - Pro - X 2 (I - 1), Tyr - Aib - Gln - Gly - Thr - Phe - Thr - Ser - Asp - Tyr - Ser - Ile - X 1 - Leu - Asp - 1 Lys - Lys - Ala - 1 Lys - Aib - Ala - Phe - Ile - Glu - Tyr - Leu - Leu - Glu - Gly - Gly - Pro - Ser - Ser - Gly - Ala - Pro - Pro - Pro - X 2 (I - 2), Tyr - Aib - Gln - Gly - Thr - Phe - Thr - Ser - Asp - Tyr - Ser - Ile - X 1 - Leu - Asp - Lys - Lys - Ala - Gln - 1 Lys - Ala - Phe - 1 Lys - Glu - Tyr - Leu - Leu - Glu - Gly - Gly - Pro - Ser - Ser - Gly - Ala - Pro - Pro - Pro - X 2 (I - 3), Tyr - Aib - Gln - Gly - Thr - Phe - Thr - Ser - Asp - Tyr - Ser - Ile - X 1 - Leu - Asp - Lys - Lys - Ala - Gln - Aib - 1 Lys - Phe - Ile - 1 Lys - Tyr - Leu - Leu - Glu - Gly - Gly - Pro - Ser - Ser - Gly - Ala - Pro - Pro - Pro - X 2 (I - 4), Tyr-Aib-Gln-Gly-Thr-Phe-Thr-Ser-Asp-Tyr-Ser-Ile-X 1 -Leu-Asp-Lys-Lys-Ala-Gln-Aib-Ala-Phe-Ile-Glu- 1 Lys-Leu-Leu- 1 Lys-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-X 2 (I-5), Tyr-Aib-Gln-Gly-Thr-Phe-Thr-Ser-Asp-Tyr-Ser-Ile-X 1 -Leu-Asp-Lys-Lys-Ala-Gln-Aib-Ala-Phe-Ile- 1 Lys-Tyr-Leu- 1 Lys-Glu-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-X 2 (II-6) (however, The structure of Aib is [Formula 1] and X 1 The structure of [chemical 2] and X 2 teeth, [C3] is selected from 1 Lys represents a modified lysine, the modification being that the amino acids of the two lysine side chains are [C4] It is linked to X is, [C5] where "*" is X 0 represents the position connected to X 0 teeth, [C6] is selected from m is selected from 2 and 3; n is selected from 8, 9, and 10; p is selected from 1 and 2.
2. The polypeptide of claim 1, wherein m is selected from 2.
3. The polypeptide of claim 1, wherein n is selected from 9.
4. The polypeptide of claim 1, wherein p is selected from 1.
5. X 2 teeth, [C7] The polypeptide of claim 1, selected from:
6. X 0 teeth, [C8] The polypeptide of claim 1, selected from:
7. Structural Units [C9] teeth, [C10] The polypeptide of claim 1, selected from:
8. A polypeptide represented by the following formula or a pharma- ceutically acceptable salt thereof: [C11] [C12] [C13] [C14] [C15] [C16]
9. A pharmaceutical composition comprising a therapeutically effective amount of the polypeptide according to any one of claims 1 to 8 or a pharma- ceutically acceptable salt thereof as an active ingredient and a pharma- ceutically acceptable carrier thereof.
10. Use of the polypeptide according to any one of claims 1 to 8 or a pharma- ceutically acceptable salt thereof, or the pharmaceutical composition according to claim 9, in the manufacture of a medicament for treating diabetes and / or obesity.
Citation Information
Patent Citations
Incretin analogs and uses thereof
WO2019125938A1
